Total Allowable Error Table

Lory McDaniel2024-08-27T15:33:36-04:00

Total Allowable Error Table

Total Allowable Error Table (Updated 20 juin24)

Click here to view the table with target values prior to 20 juin24.

Analyte	Fluid	Method	Target Value	Source
17-Hydroxyprogesterone	Serum		±2,0 nmol/L or 20% if > 10,0 nmol/L	5 RCPA
3-Methoxytyramine (3MT)	Urine		±15 nmol/L or ± 15% if > 100 nmol/L	5 RCPA
4-hydroxy-3-methoxy-mandelate, (HMMA)	Urine		±6 μmol/L or 15% if > 40 μmol/L	5 RCPA
5HIAA	Urine		±8 μmol/L or 20% if > 40 μmol/L	5 RCPA
a1-Antitrypsin (α1AT)	Serum		±0,10 g/L or 20% if > 0,5 g/L	5 RCPA
Acetaminophen (Paracetamol)	Serum		±15% or 3 µg/mL (greater)	1 CLIA, 2 WSLH, 3 CAP
Acetaminophen (Paracetamol)	Serum		±15% or 2,5 µg/mL (greater)	4 AAB
Acetaminophen (Paracetamol)	Serum		±3,0 mg/L or 10% if > 30,0 mg/L	5 RCPA
Activated Clotting Time (ACT)	Plasma		±20%	2 WSLH
Adrenaline	Urine		±30 nmol/L or 30% if > 100 nmol/L	5 RCPA
Adrenocorticotropic Hormone (ACTH)	Serum		±2,0 pmol/L or 10% if > 20 pmol/L	5 RCPA
Alanine Aminotransferase (ALT)	Serum		±15% or 6 U/L (greater)	1 CLIA, 2 WSLH, 3 CAP
Alanine Aminotransferase (ALT)	Serum		±20%	4 AAB
Alanine Aminotransferase (ALT)	Serum		±5 U/L or 12% if > 40 U/L	5 RCPA
Albumin	Serum		±8%	1 CLIA, 2 WSLH, 3 CAP
Albumin	Body Fluids		±10%	2 WSLH
Albumin	Serum		±10%	4 AAB
Albumin	Serum, Body Fluids		±2,0 g/L or 6% if > 33 g/L	5 RCPA
Albumin	CSF		±0,02 g/L or 20% if > 0,1 g/L	5 RCPA
Albumin	Urine		±4,0 mg/L or 20% if > 20,0 mg/L	5 RCPA
Alcohol (ETOH)	Serum		±20%	1 CLIA, 2 WSLH
Alcohol (ETOH)	Serum		±25%	4 AAB
Alcohol (ETOH)	Serum		±2,0 mmol/L or 10% if > 20 mmol/L	5 RCPA
Aldosterone	Serum		±24 pmol/L or 15% if > 160 pmol/L	5 RCPA
Alkaline Phosphatase (ALP)	Serum		±20%	1 CLIA, 2 WSLH, 3 CAP
Alkaline Phosphatase (ALP)	Serum		±30%	4 AAB
Alkaline Phosphatase (ALP)	Serum		±15 U/L or 12% if > 125 U/L	5 RCPA
Alpha 1 Antitrypsin	Serum		±20%	1 CLIA
Alpha-fetoprotein (AFP)	Serum		±20%	1 CLIA, 2 WSLH
Alpha-fetoprotein (AFP)	Serum		±2 kIU/L or 12% if > 17 kIU/L	5 RCPA
Aluminum	Serum		±0,08 μmol/L or 20% if > 0,40 μmol/L	5 RCPA
Amikacin	Serum		±3 SD or 10% (greater)	3 CAP
Amikacin	Serum		±2 mg/L or 10% if > 19,9 mg/L	5 RCPA
Aminolaevulinic Acid (ALA)	Urine		±8 μmol/L or 25% if > 32 μmol/L	5 RCPA
Amiodarone	Serum		±0,1 mg/L or 10% if > 1,3 mg/L	5 RCPA
Amitriptyline	Serum		±3,0 μg/L or 10% if > 28,0 μg/L	5 RCPA
Ammonia	Serum		±5% or 10 µmol/L (greater)	4 AAB
Ammonia	Serum		±5 μmol/L or 10% if > 50 μmol/L	5 RCPA
Amylase	Serum		±20%	1 CLIA, 2 WSLH, 3 CAP
Amylase	Serum		±30%	4 AAB
Amylase	Body Fluids, Urine		±30%	2 WSLH
Amylase	Serum		±10 U/L or 10% if > 100 U/L	5 RCPA
Amylase	Body Fluids		±20 U/L or 20% if > 100 U/L	5 RCPA
Androstenedione	Serum		±1,5 nmol/L or 15% if > 10 nmol/L	5 RCPA
Angiotensin Converting Enzyme (ACE)	Serum		±1,0 or 10% if > 10,0 U/L	5 RCPA
Antinuclear antibody (ANA)	Serum		±2 dilutions or positive or negative	1 CLIA
Antistreptolysin O (ASO)	Serum		±2 dilutions or positive or negative	1 CLIA
Antithrombin, Functional (AT)	Plasma		±10% or 25% if > 40%	5 RCPA
Anti HIV (Human Immunodeficiency virus)	Serum		Reactive (positive) or nonreactive (negative)	1 CLIA
Anti Xa	Plasma		±25 ng/mL or 25% if > 100 ng/mL	5 RCPA
Apolipoprotein A1	Serum		±0,2 g/L or 10% if > 2,0 g/L	5 RCPA
Apolipoprotein B	Serum		±0,2 g/L or 10% if > 2,0 g/L	5 RCPA
Arsenic, Total	Urine		±50 nmol/L or 10% if > 500 nmol/L	5 RCPA
Arsenic, Total	WB		±10 nmol/L or 10% if > 100 nmol/L	5 RCPA
Aspartate Aminotransferase (AST)	Serum		±15% or 6 U/L (greater)	1 CLIA, 2 WSLH, 3 CAP
Aspartate Aminotransferase (AST)	Serum		±20%	4 AAB
Aspartate Aminotransferase (AST)	Serum		±5 U/L or 12% if > 40 U/L	5 RCPA
Basophile, count	WB		±3% or 30% if > 10%	5 RCPA
Beta-2 microglobulin (B2M)	Serum		±0,2 mg/L or 10% if > 2,0 mg/L	5 RCPA
Beta Carotene	Serum		±0,4 μmol/L or 25% if > 2,0 μmol/L	5 RCPA
Bile Acids, Total	Serum		±4 μmol/L or 10% if > 40 μmol/L	5 RCPA
Bilirubin, Direct or Conjugated (DBIL)	Serum		±0,4 mg/dL or 20% (greater)	2 WSLH, 3 CAP
Bilirubin, Direct or Conjugated (DBIL)	Serum		±3 μmol/L or 20% if > 15 μmol/L	5 RCPA
Bilirubin, Neonatal (TBIL)	Serum		±20% or 0,4 mg/dL (greater)	4 AAB
Bilirubin, Neonatal (TBIL)	Serum		±8 μmol/L or 10% if > 80 μmol/L	5 RCPA
Bilirubin, Total	Serum		±20% or 0,4 mg/dL (greater)	1 CLIA, 2 WSLH, 3 CAP, 4 AAB
Bilirubin, Total	Serum		±3 μmol/L or 12% if > 25 μmol/L	5 RCPA
Bilirubin, Total	CSF		±0,12 μmol/L or 20% if > 0,6 μmol/L	5 RCPA
B-natriuretic Peptide (BNP)	Serum		±30%	1 CLIA, 2 WSLH
B-natriuretic Peptide (BNP)	Serum		±2 SD or 25% (greater)	4 AAB
B-natriuretic Peptide (BNP)	Serum		±20 ng/L or 20% if > 100 ng/L	5 RCPA
B-natriuretic Peptide, Pro (proBNP)	Serum		±30%	2 WSLH
B-natriuretic Peptide, Pro (proBNP)	Serum		±25%	4 AAB
B-natriuretic Peptide, Pro (proBNP)	Serum		±25 ng/L or 20% if > 125 ng/L	5 RCPA
C Peptide	Serum		±0,15 nmol/L or 12% if > 1,25 nmol/L	5 RCPA
C1 Inhibitor, Esterase (C1inh)	Serum		±0,03 g/L or 15% if > ±0,2 g/L	5 RCPA
Cadmium	Urine, WB		±1 mg/dL or 15%	2 WSLH
Cadmium	Urine, WB		±3 nmol/L or 15% if > 20 nmol/L	5 RCPA
Caffeine	Serum		±3 SD or 10% (greater)	3 CAP
Calcitonin	Serum		±2 ng/L or 10% if > 20 ng/L	5 RCPA
Calcium - Total	Serum		±1,0 mg/dL	1 CLIA, 2 WSLH, 3 CAP, 4 AAB
Calcium - Total	Urine		±10% or 1 mg/dL	2 WSLH
Calcium - Total	Serum		±0,1 mmol/L or 4% if > 2,5 mmol/L	5 RCPA
Calcium - Total	Urine		±0,2 mmol/L or 10% if > 2,0 mmol/L	5 RCPA
Calcium, Ionized	Serum		±0,13 mmol/L	2 WSLH
Calcium, Ionized	Serum		±0,04 mmol/L or 4% if > 1,00 mmol/L	5 RCPA
Cancer Antigen (CA) 125	Serum		±6 kU/L or 12% if > 50 kU/L	5 RCPA
Cancer Antigen (CA) 15-3	Serum		±2 SD or 30% (greater)	4 AAB
Cancer Antigen (CA) 15-3	Serum		±3 kU/L or 10% if > 30 kU/L	5 RCPA
Cancer Antigen (CA) 19-9	Serum		±2 SD or 30% (greater)	4 AAB
Cancer Antigen (CA) 19-9	Serum		±6 kU/L or 15% if > 40 kU/L	5 RCPA
Cancer Antigen (CA) 19-9	Body Fluids		±12 kU/L or 30% if > 40 kU/L	5 RCPA
Cancer Antigen (CA) 27,29	Serum		±2 SD or 30% (greater)	4 AAB
Carbamazepine	Serum		±20% or 1,0 µg/mL (greater)	1 CLIA, 2 WSLH, 3 CAP
Carbamazepine	Serum		±25%	4 AAB
Carbamazepine	Serum		±0,5 mg/L or 10% if > 4,7 mg/L	5 RCPA
Carbamazepine, Free	Serum		±3 SD or 10% (greater)	3 CAP
Carcinoembryonic Antigen (CEA)	Serum		±15% or 1 ng/mL (greater)	1 CLIA, 2 WSLH
Carcinoembryonic Antigen (CEA)	Serum		±1,2 ng/mL or 20%	4 AAB
Carcinoembryonic Antigen (CEA)	Serum		±0,6 μg/L or 12% if > 5 μg/L	5 RCPA
Carcinoembryonic Antigen (CEA)	Body Fluids		±1,2 μg/L or 24% if > 5,0 μg/L	5 RCPA
Carotenoids, Total	Serum		±0,8 μmol/L or 25% if > 4,0 μmol/L	5 RCPA
CD3+ Alpha-beta%	WB		±4,5% to 15% if > 30%	5 RCPA
CD3+%	WB		±1,5% or 5% if > 30%	5 RCPA
CD3x109/L	WB		±0.02x109/L or 20% if > 0.1x109/L	5 RCPA
CD4x109/L	WB		±0.02x109/L or 20% if > 0.1x109/L	5 RCPA
CD3+/CD4+%	WB		±3% or 7,5% if > 40%	5 RCPA
CD3+/CD8+%	WB		±1,5% or 10% if > 15%	5 RCPA
CD3-CD16+%	WB		±2% or 20% if > 10%	5 RCPA
CD3-CD56+%	WB		±2% or 20% if > 10%	5 RCPA
CD3-CD16+56+%	WB		±2% or 20% if > 10%	5 RCPA
CD8x109/L	WB		±0.02x109/L or 20% if > 0.1x109/L	5 RCPA
CD19+%	WB		±2% or 20% if > 10%	5 RCPA
CD19x109/L	WB		±0.02x109/L or 20% if > 0.1x109/L	5 RCPA
CD34+, %	WB		±0,05% or 25% if > 0,3%	5 RCPA
CD34+, Total	WB		±5 μL or 25% if > 20 μL	5 RCPA
Ceruloplasmin	Serum		±0,03 g/L or 15% if > 0,2 g/L	5 RCPA
Chloride	Serum		±5%	1 CLIA, 2 WSLH, 3 CAP, 4 AAB
Chloride	Urine		±10%	2 WSLH
Chloride	Serum		±3 mmol/L or 3% if > 100 mmol/L	5 RCPA
Chloride	Sweat		±2,0 mmol/L or 5% if > 40 mmol/L	5 RCPA
Chloride	Urine		±4,0 mmol/L or 10% if > 40 mmol/L	5 RCPA
Cholesterol, HDL	Serum		±20% or 6 mg/dL (greater)	1 CLIA, 2 WSLH, 3 CAP
Cholesterol, HDL	Serum		±30%	4 AAB
Cholesterol, HDL	Serum		±0,1 mmol/L or 12% if > 0,8 mmol/L	5 RCPA
Cholesterol, LDL	Serum		±20%	1 CLIA, 2 WSLH, 3 CAP
Cholesterol, LDL	Serum		±30%	4 AAB
Cholesterol, LDL	Serum		±0,2 mmol/L or 10% if > 2,0 mmol/L	5 RCPA
Cholesterol, Total	Serum		±10%	1 CLIA, 2 WSLH, 3 CAP, 4 AAB
Cholesterol, Total	Body Fluids		±10%	2 WSLH
Cholesterol, Total	Serum		±0,3 mmol/L or 6% if > 5,0 mmol/L	5 RCPA
Cholesterol, Total	Body Fluids		±0,3 mmol/L or 12% if > 2,5 mmol/L	5 RCPA
Cholinesterase	Serum		±500 U/L or 10% if > 5000 U/L	5 RCPA
Chromium	Serum, Urine, WB		±3 nmol/L or 12% if > 25 nmol/L	5 RCPA
Clozapine	Serum		±12 μg/L or 12% if > 100 μg/L	5 RCPA
CO2, Carbon Dioxide (Bicarbonate)	Serum		±20%	1 CLIA, 2 WSLH, 3 CAP, 4 AAB
CO2, Carbon Dioxide (Bicarbonate)	Serum		±2,0 mmol/L or 10% if > 20,0 mmol/L	5 RCPA
Cobalt	Plasma		±1 nmol/L or 10% if > 10 nmol/L	5 RCPA
Cobalt	Urine		±2 nmol/L or 10% if > 20 nmol/L	5 RCPA
Cobalt	WB		±2 nmol/L or 10% if > 10 nmol/L	5 RCPA
Compatibility testing	Serum		100% accuracy	1 CLIA
Complement C3	Serum		±15%	1 CLIA
Complement C3	Serum		±0,10 g/L or 10% if > 1,0 g/L	5 RCPA
Complement C4	Serum		±20% or 5 mg/dL (greater)	1 CLIA
Complement C4	Serum		0,02 g/L or 10% if > 0,2 g/L	5 RCPA
Conductivity	Sweat		±2 mmol/L or 5% if > 50 mmol/L	5 RCPA
Copper	Serum		±1,6 μmol/L or 8% if > 20,0 μmol/L	5 RCPA
Copper	Urine		±0,05 μmol/L or 10% if > 0,50 μmol/L	5 RCPA
Cortisol	Serum		±20%	1 CLIA, 2 WSLH, 3 CAP
Cortisol	Serum		±25%	4 AAB
Cortisol	Serum		±15 nmol/L or 15% if > 100 nmol/L	5 RCPA
Cortisol	Urine		±30 nmol/L or 15% if > 200 nmol/L	5 RCPA
C-Reactive protein (CRP)	Serum		±30% or 2 SD (greater)	4 AAB
C-Reactive protein (CRP)	Serum		±0,8 mg/L or 20% if > 4,0 mg/L	5 RCPA
C-Reactive protein (CRP), High Sensitivity	Serum		±30% or 1 mg/L (greater)	1 CLIA, 2 WSLH, 4 AAB
C-Reactive protein (CRP), High Sensitivity	Serum		±0,6 mg/L or 20% if > 3,0 mg/L	5 RCPA
Creatine Kinase (CK)	Serum		±20%	1 CLIA, 2 WSLH, 3 CAP
Creatine Kinase (CK)	Serum		±30%	4 AAB
Creatine Kinase (CK)	Serum		±15 U/L or 12% if > 125 U/L	5 RCPA
Creatine Kinase Isoenzyme (CKMB)	Serum		±25% or 3 ng/mL (greater) or MB elevated (presence or absence)	1 CLIA, 2 WSLH
Creatine Kinase Isoenzyme (CKMB)	Serum		±3 U/L or 3 μg/L or 20% if > 15 U/L or 15 μg/L	5 RCPA
Creatinine	Serum		±10% or 0,2 mg/dL (greater)	1 CLIA, 2 WSLH, 3 CAP
Creatinine	Body Fluids, Urine		±17% or 0,3 mg/dL	2 WSLH
Creatinine	Serum		±0,3 mg/dL or 15% (greater)	4 AAB
Creatinine	Serum, Urine		±17%	4 AAB
Creatinine	Serum		±8,0 μmol/L or 8% if > 100 μmol/L	5 RCPA
Creatinine	Body Fluids		±16,0 μmol/L or 16% if > 100 μmol/L	5 RCPA
Creatinine	Urine		±0,5 mmol/L or 10% if > 5,0 mmol/L	5 RCPA
Cyclosporine	Serum		±10 μg/L or 10% if > 100 μg/L	5 RCPA
d-Dimer	Plasma		±15%	2 WSLH
d-Dimer	Plasma		±2 SD or 30% (greater)	4 AAB
d-Dimer	Plasma	automated DD	±0,25 DD mg/L or 50% if > 0,5 DD mg/L	5 RCPA
d-Dimer	Plasma	automated FEU	±0,5 FEU mg/L or 50% if > 1,0 FEU mg/L	5 RCPA
DHEA Sulfate	Serum		±30% or 2 SD (greater)	4 AAB
DHEA Sulfate	Serum		±1,2 μmol/L or 12% if > 10 μmol/L	5 RCPA
Digoxin	Serum		±15% or 0,2 ng/mL (greater)	1 CLIA, 2 WSLH, 3 CAP
Digoxin	Serum		±0,2 ng/dL or 20% (greater)	4 AAB
Digoxin	Serum		±0,2 μg/L or 10% if > 1,6 μg/L	5 RCPA
Digoxin, Free	Serum		±3 SD or 10% (greater)	3 CAP
Dihydropyrimidine dehydrogenase (DPYD) Free	Urine		±15 nmol/L or 15% if > 80 nmol/L	5 RCPA
Direct Thrombin Inhibitor, (DTI)	Plasma		±25 ng/mL or 25% if >100 ng/mL	5 RCPA
Disopyramide	Serum		±3 SD or 10% (greater)	3 CAP
Dopamine	Urine		±0,2 μmol/L or 10% if > 2,0 μmol/L	5 RCPA
Eosinophils, count	WB		±3% or 30% if > 10%	5 RCPA
Erythrocyte Sedimentation Rate (ESR)	WB		±3,0 mm/hr or 30% if > 10 mm/hr	5 RCPA
Estradiol	Serum		±30%	1 CLIA, 2 WSLH, 4 AAB
Estradiol (Oestradiol)	Serum		±25 pmol/L or 25% if > 100 pmol/L	5 RCPA
Estriol, Unconjugated (Oestriol)	Serum		±0,9 nmol/L or 15% if > 6,0 nmol/L	5 RCPA
Ethosuximide	Serum		±20%	3 CAP
Factor II, V, VII, IX, X, XI, XII	Plasma		±3 IU/dL or 30% if > 10 IU/dL	5 RCPA
Factor VIII:C	Plasma		±3% or 30% if > 10%	5 RCPA
Fecal Occult Blood (FOBT)	Stool		±15 ng/mL or 15% if > 100 ng/mL	5 RCPA
Ferritin	Serum		±20%	1 CLIA, 2 WSLH, 3 CAP, 4 AAB
Ferritin	Serum		±4,0 μg/L or 15% if 27,0 μg/L	5 RCPA
Fibrinogen	Plasma		±20%	1 CLIA, 2 WSLH, 4 AAB
Fibrinogen	Plasma		±0,2 g/L or 25% if > 1,0 g/L	5 RCPA
Fluconazole	Serum		±2,0 mg/L or 10% if > 20 mg/L	5 RCPA
Flucytosine	Serum		±10 mg/L or 10% if > 100 mg/L	5 RCPA
Folate	Serum		±30% or 1 ng/mL (greater)	1 CLIA, 2 WSLH, 4 AAB
Folate	Serum		±1,5 nmol/L or 25% if > 6,0 nmol/L	5 RCPA
Folate, RBC	WB		±80 nmol/L or 20% if > 400 nmol/L	5 RCPA
Follicle Stimulating Hormone (FSH)	Serum		±18% or 2 IU/L (greater)	1 CLIA, 2 WSLH, 4 AAB
Follicle Stimulating Hormone (FSH)	Serum		±1,0 IU/L or 10% if > 10,0 IU/L	5 RCPA
Fractional Carboxyhemoglobin	WB		±1% or 20% if > 5%	5 RCPA
Fractional Methemoglobin	WB		±2% or 10% if > 20%	5 RCPA
Fractional Oxyhemoglobin	WB		±3% or 4% if > 75%	5 RCPA
Fructosamine	Serum		±15 μmol/L or 6% if > 250 μmol/L	5 RCPA
Gamma glutamyl transferase (GGT)	Serum		±15% or 5 U/L (greater)	1 CLIA, 2 WSLH, 3 CAP
Gamma glutamyl transferase (GGT)	Serum		±2 SD or 15% (greater)	4 AAB
Gamma glutamyl transferase (GGT)	Serum		±5 U/L or 12% if > 40 U/L	5 RCPA
Gastrin	Serum		±10 pmol/L or 10% if > 100 pmol/L	5 RCPA
Gentamicin	Serum		±25%	1 CLIA, 2 WSLH, 3 CAP
Gentamicin	Serum		±25% or 1,0 µg/mL (greater)	4 AAB
Gentamicin	Serum		±0,2 mg/L or 10% if > 2,0 mg/L	5 RCPA
Glucose	Serum		±8% or 6 mg/dL (greater)	1 CLIA, 2 WSLH, 3 CAP
Glucose	Body Fluids, CSF, Urine		±10%	2 WSLH
Glucose	WB		±20% or 15 mg/dL	2 WSLH
Glucose	Serum		±6 mg/dL or 10% (greater)	4 AAB
Glucose	WB		±6 mg/dL or 20% (greater)	4 AAB
Glucose	Serum, Body Fluids		±0,4 mmol/L or 8% if > 5,0 mmol/L	5 RCPA
Glucose	CSF		±0,2 mmol/L or 10% if > 2,0 mmol/L	5 RCPA
Glucose	Urine		±1,0 mmol/L or 10% if > 10,0 mmol/L	5 RCPA
Glucose-6-phosphate-1-dehydrogenase (G6PD)	WB		±3,0 U/g Hb or 30% if > 10 U/g Hb	5 RCPA
Growth Hormone	Serum		±1,0 mU/L or 15% if > 7,0 mU/L	5 RCPA
Haptoglobin	Serum		±0,1 g/L or 10% if > 0,8 g/L	5 RCPA
Hematocrit	WB		±4%	1 CLIA, 2 WSLH
Hematocrit	WB		±6 mg/dL or 20% (greater)	4 AAB
Hematocrit	WB		±4% or 20% if > 20%	5 RCPA
Hemoglobin	WB		±4%	1 CLIA, 2 WSLH
Hemoglobin	WB		±7%	4 AAB
Hemoglobin	WB		±5 g/L or 5% if > 100 g/L	5 RCPA
Hemoglobin A1c (Glycohemoglobin)	WB		±8%	1 CLIA, 2 WSLH
Hemoglobin A1c (Glycohemoglobin)	WB		±5%	4 AAB
Hemoglobin A1c (Glycohemoglobin)	WB	IFCC	±4 mmol/mol or 8% if > 45 mmol/mol	5 RCPA
Hemoglobin A1c (Glycohemoglobin)	WB	NGSP	±0,4% or 6% if > 6,7%	5 RCPA
Hemoglobin, A2	WB		±0,3% or 10% if > 2,0	5 RCPA
Hemoglobin, F	WB		±0,5% or 30% if > 1,5%	5 RCPA
Hemoglobin, Variant	WB		±4% or 20% if > 20,0%	5 RCPA
Hemolysis, Serum Index	Serum		±8 mg/dL or 10% if > 80 mg/dL	5 RCPA
Hepatitis (Anti-HBc, HBsAg, HBeAg, Anti-HCV)	Serum		Reactive (positive) or nonreactive (negative)	1 CLIA, 2 WSLH
Hepatitis, Surface Antibody (Anti-HBs)	Serum		Reactive (positive) or nonreactive (negative)	1 CLIA, 2 WSLH
Homocysteine	Serum		±30%	4 AAB
Homocysteine	Serum		±1,5 μmol/L or 10% if > 15 μmol/L	5 RCPA
Homovanillic Acid (HVA)	Urine		±6 μmol/L or 15% if > 40 μmol/L	5 RCPA
Human Chorionic Gonadotropin (HCG)	Serum		±18% or 3 mIU/mL (greater) or positive or negative	1 CLIA, 2 WSLH, 3 CAP
Human Chorionic Gonadotropin (HCG)	Serum		±18% or 2 SD (greater)	4 AAB
Human Chorionic Gonadotropin (HCG)	Serum		±1,0 IU/L or 10% if > 10,0 IU/L	5 RCPA
Human Chorionic Gonadotropin (HCG)	Urine		±5,0 IU/L or 10% if > 50 IU/L	5 RCPA
Hydroxyitraconazole	Serum		±0,2 mg/L or 10% if > 2,0 mg/L	5 RCPA
Icterus, Serum Index	Serum		±6,0 μmol/L or 25% if > 25,0 μmol/L	5 RCPA
IgA	Serum		±20%	1 CLIA
IgA	Serum		±0,06 g/L or 10% if > 0,6 g/L	5 RCPA
IgD	Serum		±0,2 g/L or 20% if > 1,0 g/L	5 RCPA
IgE	Serum		±20%	1 CLIA
IgE	Serum		±20 kU/L or 20% if > 100 kU/L	5 RCPA
IgG	Serum		±20%	1 CLIA
IgG	Serum		±25%	4 AAB
IgG	Serum		±0,6 g/L or 10% if > 6 g/L	5 RCPA
IgG	CSF		±0,02 g/L or 20% if > 0,1 g/L	5 RCPA
IgM	Serum		±20%	1 CLIA
IgM	Serum		±0,08 g/L or 15% If > 0,5 g/L	5 RCPA
Immature granulocytes (IG's)	WB		±3% or 30% if > 10%	5 RCPA
Infectious mononucleosis	Serum		±2 dilutions or positive or negative	1 CLIA, 2 WSLH
INR	Plasma		±15%	1 CLIA, 2 WSLH, 4 AAB
INR	Plasma		±0,3 ratio or 15% if > 2,0 ratio	5 RCPA
Insulin	Serum		±6 mU/L or 12% if > 5 mU/L	5 RCPA
Insulin-like Growth Factor (IGF-1)	Serum		±3 nmol/L or 12% if > 25 nmol/L	5 RCPA
Insulin-like Growth Factor Binding Protein (IGFBP-3)	Serum		±15 nmol/L or 15% if > 100 nmol/L	5 RCPA
Iodine	Urine		±80 nmol/L or 10% if > 800 nmol/L	5 RCPA
Iron (Fe)	Serum		±15%	1 CLIA, 2 WSLH, 3 CAP
Iron (Fe)	Serum		±20%	4 AAB
Iron (Fe)	Serum, Urine		±3,0 μmol/L or 12% if > 25,0 μmol/L	5 RCPA
Iron Binding Capacity, Total (IBC)	Serum		±20%	1 CLIA, 2 WSLH, 3 CAP, 4 AAB
Iron Binding Capacity, Total (IBC)	Serum, Urine		±20%	4 AAB
Iron Binding Capacity, Total (IBC)	Serum		±4 μmol/L or 8% if > 50,0 μmol/L	5 RCPA
Iron Binding Capacity, Unsaturated (UIBC)	Serum		±20%	2 WSLH
Itraconazole	Serum		±0,1 mg/L or 10% if > 1,0 mg/L	5 RCPA
Lactate	Serum		±0,2 mmol/L	2 WSLH
Lactate	CSF		±10%	2 WSLH
Lactate	Serum		±0,4 mmol/L or 3 SD (greater)	3 CAP, 4 AAB
Lactate	Serum		±0,5 mmol/L or 12% if > 4,0 mmol/L	5 RCPA
Lactate	CSF		±0,3 mmol/L or 10% if > 3,0 mmol/L	5 RCPA
Lactate	Body Fluids		±1,0 mmol/L or 25% if > 4,0 mmol/L	5 RCPA
Lactate Dehydrogenase (LD, LDH)	Serum		±15%	1 CLIA, 2 WSLH, 3 CAP
Lactate Dehydrogenase (LD, LDH)	Body Fluids		±20%	2 WSLH
Lactate Dehydrogenase (LD, LDH)	Serum		±20%	4 AAB
Lactate Dehydrogenase (LD, LDH)	Serum, Body Fluids		±20 U/L or 8% if > 250 U/L	5 RCPA
Lead (Pb)	WB		±10% or 2 µg/dL (greater)	1 CLIA, 2 WSLH
Lead (Pb)	WB		±4 µg/dL or 10% (greater)	4 AAB
Lead (Pb)	Urine		±50 nmol/L or 10% if > 500 nmol/L	5 RCPA
Lead (Pb)	WB		±0,05 μmol/L or 10% if > 0,50 μmol/L	5 RCPA
Lidocaine	Serum		±3 SD or 10% (greater)	3 CAP
Lipase	Serum		±30%	2 WSLH, 3 CAP, 4 AAB
Lipase	Serum		±12 U/L or 20% if > 60 U/L	5 RCPA
Lipase	Body Fluids		±24 U/L or 40% if > 60 U/L	5 RCPA
Lipemia, Serum Index	Serum		±26 mg/dL or 10% if > 263 mg/dL	5 RCPA
Lipoprotein (a)	Serum		±0,06 g/L or 20% if > 0,3 g/L	5 RCPA
Lithium	Serum		±15% or 0,3 mmol/L (greater)	1 CLIA, 2 WSLH, 3 CAP
Lithium	Serum		±0,3 mmol/L or 20% (greater)	4 AAB
Lithium	Serum		±0,2 mmol/L or 10% if > 2,0 mmol/L	5 RCPA
Luteinizing Hormone (LH)	Serum		±20%	1 CLIA, 2 WSLH, 3 CAP, 4 AAB
Luteinizing Hormone (LH)	Serum		±1,5 IU/L or 15% if > 10,0 IU/L	5 RCPA
Lymphocytes, count	WB		±2% or 20% if > 10%	5 RCPA
Magnesium	Serum		±15%	1 CLIA, 2 WSLH, 3 CAP
Magnesium	Urine		±25%	2 WSLH
Magnesium	Serum		±25%	4 AAB
Magnesium	Serum, WB		±0,1 mmol/L or 8% if > 1,25 mmol/L	5 RCPA
Magnesium	Urine		±0,3 mmol/L or 15% if > 2,0 mmol/L	5 RCPA
Magnesium	Urine		±0,1 mmol/L or 8% if > 1,25 mmol/L	5 RCPA
Manganese	Serum		±0,1 nmol/L or 8% if	5 RCPA
Manganese	Urine		±3 nmol/L or 12% if > 25 nmol/L	5 RCPA
Manganese	WB		±30 nmol/L or 12% if > 250 nmol/L	5 RCPA
Mean corpuscular hemoglobin (MCH)	WB		±2 pg or 10% if > 20 pg	5 RCPA
Mean corpuscular hemoglobin concentration (MCHC)	WB		±30 g/L or 10% if > than 300 g/L	5 RCPA
Mean corpuscular volume (MCV)	WB		±5 fL or 10% if > 50 fL	5 RCPA
Mean platelet volume (MPV)	WB		±2 fL or 20% if > 10 fL	5 RCPA
Metanephrine	Plasma		±75 pmol/L or 15% if > 500 pmol/L	5 RCPA
Metanephrine	Urine		±0,2 μmol/L or 20% if > 1,0 μmol/L	5 RCPA
Metanephrine, Free	Urine		±30 nmol/L or 30% if > 100 nmol/L	5 RCPA
Methemoglobin	WB		±0,003	2 WSLH
Methotrexate	Serum		±3 SD or 10% (greater)	3 CAP
Methotrexate	Serum		±0,10 μg/L or 10% if > 1,00 μmol/L	5 RCPA
Methyoxytyramine	Plasma		±36 pmol/L or 30% if > 120 pmol/L	5 RCPA
Mercury	Serum		±30% or 3 ug/L	2 WSLH
Mercury	Serum, Urine, WB		±9 nmol/L or 15% if > 60 nmol/L	5 RCPA
Microalbumin	Urine		±10%	2 WSLH
Microalbumin	Urine		±30%	4 AAB
Monocytes, count	WB		±3% or 30% if > 10%	5 RCPA
Mycophenolate	Serum		±0,10 μg/L or 10% if > 1,00 mg/L	5 RCPA
Myoglobin	Serum		±2 SD or 30% (greater)	4 AAB
N-Acetylprocainamide (NAPA)	Serum		±25%	3 CAP
Neuron-specific enolase (NSE)	Serum		±2 μg/L or 10% if > 20 μg/L	5 RCPA
Neutrophil, count	WB	automated	±1% or 10% if > 10,0%	5 RCPA
Nickel	Urine		±40 nmol/L or 10% if > 400 nmol/L	5 RCPA
Noradrenaline	Urine		±75 nmol/L or 15% if > 500 nmol/L	5 RCPA
Normetanephrine	Plasma		±200 pmol/L or 20% if > 1000 pmol/L	5 RCPA
Normetanephrine	Urine		±0,4 μmol/L or 20% if > 2,0 μmol/L	5 RCPA
Normetanephrine, Free	Urine		±40 nmol/L or 20% if > 200 nmol/L	5 RCPA
Nortriptyline	Serum		±3,0 μg/L or 10% if > 26,0 μg/L	5 RCPA
N-Telopeptides	Urine		±80 nmolBCE/L or 10% if > 700 nmolBCE/L	5 RCPA
Osmolality	Urine		±10%	2 WSLH
Osmolality	Serum, Body Fluids		±8 mmol/kg or 3% if > 266 mmol/kg	5 RCPA
Osmolality	Urine		±6 mmol/kg or 2% if > 300 mmol/kg	5 RCPA
Pancreatic Amylase	Serum		±30%	3 CAP
Parathyroid hormone (PTH)	Serum		±30%	1 CLIA, 2 WSLH, 4 AAB
Parathyroid Hormone (PTH)	Serum		±1,0 pmol/L or 12% if > 8,0 pmol/L	5 RCPA
Partial thromboplastin time (PTT), (aPTT)	Plasma		±15%	1 CLIA, 2 WSLH, 4 AAB
Partial thromboplastin time (PTT), (aPTT)	Plasma		±10 sec or 25% if > 40 sec	5 RCPA
pCO2	WB		±8% or 5 mmHg (greater)	1 CLIA, 2 WSLH, 4 AAB
pCO2	WB		±2 mm Hg or 6% if > 34,0 mm Hg	5 RCPA
pH	WB		±0,04	1 CLIA, 2 WSLH, 4 AAB, 5 RCPA
pH	Body Fluids		±0,5	2 WSLH
pH	Body Fluids		±0,02	5 RCPA
Phenobarbital	Serum		±15% or 2 µg/mL (greater)	1 CLIA, 2 WSLH, 3 CAP
Phenobarbital	Serum		±20%	4 AAB
Phenobarbitone	Serum		±0,7 mg/L or 10% if > 7,0 mg/L	5 RCPA
Phenytoin	Serum		±15% or 2 µg/mL (greater)	1 CLIA, 2 WSLH, 3 CAP
Phenytoin	Serum		±25%	4 AAB
Phenytoin	Serum		±0,8 mg/L or 10% if > 7,6 mg/L	5 RCPA
Phenytoin, Free	Serum		±3 SD or 10% (greater)	3 CAP
Phosphate	Serum		±0,06 mmol/L or 8% if > 0,75 mmol/L	5 RCPA
Phosphate	Urine		±3 mmol/L or 15% if > 20 mmol/L	5 RCPA
Phosphorus	Serum		±10% or 0,3 mg/dL (greater)	1 CLIA, 2 WSLH, 3 CAP, 4 AAB
Phosphorus	Urine		±15% or 0,5 mg/dL	2 WSLH
Platelet count	WB		±25%	1 CLIA, 2 WSLH, 3 CAP, 4 AAB
Platelet count	WB		±25x109/L or 25% If > 100x109/L	5 RCPA
pO2	WB		±15% or 15 mmHg (greater)	1 CLIA, 2 WSLH
pO2	WB		±5 mm Hg or 6% if > 83 mm Hg	5 RCPA
Porphobilinogen	Urine		±5 μmol/L or 25% if > 20 μmol/L	5 RCPA
Porphyrin, Total	Plasma		±4 nmol/L or 20% if > 20 nmol/L	5 RCPA
Porphyrin, Total	Urine		±60 nmol/ or 20% if > 300 nmol/L	5 RCPA
Porphyrin, Total	Fecal		±40 μmol/kg or 20% if > 200 μmol/kg	5 RCPA
Porphyrin, Total RBC	WB		±0,4 μmol/Lrc or 20% if > 2,0 μmol/Lrc	5 RCPA
Posaconazole	Serum		±0,1 mg/L or 10% if > 1,0 mg/L	5 RCPA
Potassium (K)	Serum		±0,3 mmol/L	1 CLIA, 2 WSLH, 3 CAP
Potassium (K)	Urine		±10%	2 WSLH
Potassium (K)	Serum		±0,5 mmol/L	4 AAB
Potassium (K)	Serum		±0,2 mmol/L or 5% if > 4,0 mmol/L	5 RCPA
Potassium (K)	Body Fluids		±0,4 mmol/L or 10% if > 4 mmol/L	5 RCPA
Potassium (K)	Urine		±2 mmol/L or 10% > 20 mmol/L	5 RCPA
Prealbumin	Serum		±5,0 mg/dL or 25% (greater)	3 CAP
Prealbumin	Serum		±25%	4 AAB
Prealbumin	Serum		±0,04 g/L or 20% if > 0,2 g/L	5 RCPA
Primidone	Serum		±25%	3 CAP
Pro B-natriuretic Peptide (proBNP)	Serum		±30%	1 CLIA
Procainamide	Serum		±25%	3 CAP
Procalcitonin	Serum		±0,05 ng/mL or 30% if > 0,15 ng/mL	5 RCPA
Progesterone	Serum		±25%	1 CLIA, 2 WSLH, 4 AAB
Progesterone	Serum		±2 nmol/L or 15% if > 10 nmol/L	5 RCPA
Prolactin	Serum		±20%	1 CLIA, 2 WSLH, 4 AAB
Prolactin	Serum		±40 mIU/L or 10% if > 400 mIU/L	5 RCPA
Prostate Specific Antigen (PSA)	Serum		±20% or 0,2 ng/mL (greater)	1 CLIA, 2 WSLH
Prostate Specific Antigen (PSA)	Serum		±0,9 ng/mL or 30%	4 AAB
Prostate Specific Antigen (PSA)	Serum, Urine		±0,4 μg/L or 8% if > 5,0 μg/L	5 RCPA
Prostate Specific Antigen (PSA), Free	Serum		±30% or 0,9 ng/mL	2 WSLH
Prostate Specific Antigen (PSA), Free	Serum		±0,9 ng/mL or 30%	4 AAB
Prostate Specific Antigen (PSA), Free	Serum		±0,2 μg/L or 15% if > 1,4 μg/L	5 RCPA
Protein, Total	Serum		±8%	1 CLIA, 2 WSLH, 3 CAP
Protein, Total	Body Fluids, CSF, Urine		±10%	2 WSLH
Protein, Total	Serum		±10%	4 AAB
Protein, Total	Urine		±44%	4 AAB
Protein, Total	Serum, Body Fluids		±3,0 g/L or 5% if > 60 g/L	5 RCPA
Protein, Total	CSF		±0,05 g/L or 10% if > 0,5 g/L	5 RCPA
Protein, Total	Urine		±0,1 g/L or 10% if > 1,00 g/L	5 RCPA
Protein C, Functional	Plasma		±12% or 20% if > 60%	5 RCPA
Protein S, Free Antigen	Plasma		±10% or 25% if > 40%	5 RCPA
Protein S, Free Functional	Plasma		±10% or 25% if > 40%	5 RCPA
Protein S, Total Antigen	Plasma		±10% or 25% if > 40%	5 RCPA
Prothrombin Time (PT)	Serum		±15%	1 CLIA, 2 WSLH, 4 AAB
Prothrombin Time (PT)	Plasma		±2,0 sec or 20% if > 10 sec	5 RCPA
Quinidine	Serum		±25%	3 CAP
RBC, Red Cell count, Erythrocyte Count	WB	automated differential	±4%	1 CLIA, 2 WSLH
RBC, Red Cell count, Erythrocyte Count	WB	quantitative	±6%	4 AAB
Red Cell Distribution Width (RDW)	WB		2% or 20% if > 10%	5 RCPA
Reticulocyte count	WB		±30% or 2 SD (greater)	4 AAB
Reticulocyte count	WB	automated %	±1,0% or 10% if > 10%	5 RCPA
Reticulocyte count	WB	automated absolute	±10x109/L or 10% if > 100x109/L	5 RCPA
Reticulocyte count	WB	manual %	±0,6% or 30% if > 2%	5 RCPA
Reticulocyte count	WB	manual absolute	±21x109/L or 30% if > 70x109/L	5 RCPA
Rheumatoid Factor (RF)	Serum		±2 dilutions or positive or negative	1 CLIA, 2 WSLH
Rheumatoid Factor (RF)	Serum		±12 IU/mL or 20% if > 60 IU/mL	5 RCPA
Rubella	Serum		±2 dilutions or positive or negative or immune or nonimmune	1 CLIA, 2 WSLH
Salicylates	Serum		±15% or 2 µg/mL (greater)	1 CLIA, 2 WSLH, 3 CAP
Salicylates	Serum		±25%	4 AAB
Salicylates	Serum		±14 mg/L or 10% if > 143,0 mg/L	5 RCPA
Selenium	Serum		±0,18 μmol/L or 12% if > 1,50 μmol/L	5 RCPA
Selenium	Urine		±0,06 μmol/L or 12% if > 0,50 μmol/L	5 RCPA
Selenium	WB		±0,3 μmol/L or 12% if > 2,50 μmol/L	5 RCPA
Serotonin	Urine		±0,2 μmol/L or 20% if > 1,0 μmol/L	5 RCPA
Sex hormone binding globulin (SHBG)	Serum		±6 nmol/L or 12% if > 50 nmol/L	5 RCPA
Sirolimus	Serum		±0,5 μg/L or 10% if > 5,0 μg/L	5 RCPA
Sodium (Na)	Serum		±4 mmol/L	1 CLIA, 2 WSLH, 3 CAP, 4 AAB
Sodium (Na)	Urine		±10% or 4 mmol/L	2 WSLH
Sodium (Na)	Serum		±3 mmol/L or 2% if > 150 mmol/L	5 RCPA
Sodium (Na)	Body Fluids		±6 mmol/L or 4% if > 150 mmol/L	5 RCPA
Sodium (Na)	Urine		±4 mmol/L or 10% if > 40 mmol/L	5 RCPA
Specific Gravity	Urine		±0,010	2 WSLH, 4 AAB
T3 Free, (FT3) Triiodothyronine, Free	Serum		±0,7 pmol/L or 20% if > 3,5 pmol/L	5 RCPA
T3, Total Triiodothyronine	Serum		±30%	1 CLIA, 2 WSLH, 3 CAP
T3, Total Triiodothyronine	Serum		±0,2 nmol/L or 15% if > 1,3 nmol/L	5 RCPA
T3 Uptake	Serum		±18%	1 CLIA, 2 WSLH, 3 CAP
T4, Thyroxine	Serum		±20% or 1,0 µg/dL (greater)	1 CLIA, 2 WSLH, 3 CAP, 4 AAB
T4, Thyroxine	Serum		±12 nmol/L or 10% if > 120 nmol/L	5 RCPA
T4, Free Thyroxine, (FT4)	Serum		±15% or 0,3 ng/dL (greater)	1 CLIA, 2 WSLH, 3 CAP
T4, Free Thyroxine, (FT4)	Serum		±1,5 pmol/L or 12% if > 12,0 pmol/L	5 RCPA
Tacrolimus	Serum		±0,5 μg/L or 10% if > 5,0 μg/L	5 RCPA
Testosterone	Serum		±30% or 20 ng/dL (greater)	1 CLIA, 2 WSLH, 4 AAB
Testosterone	Serum		±0,4 nmol/L or 15% if > 2,7 nmol/L	5 RCPA
Thallium	Serum, Urine		±1 nmol/L or 10% if > 10 nmol/L	5 RCPA
Thallium	WB		±2 nmol/L or 10% if > 10 nmol/L	5 RCPA
Theophylline	Serum		±20%	1 CLIA, 2 WSLH, 3 CAP
Theophylline	Serum		±25%	4 AAB
Theophylline	Serum		±0,5 mg/L or 10% if > 5,4 mg/L	5 RCPA
Thrombin Time (TT)	Plasma		±3,0 sec or 25% if > 12,0 sec	5 RCPA
Thyroglobulin	Serum		±0,2 μg/L or 12% if > 1,7 μg/L	5 RCPA
Thyroid stimulating Hormone (TSH)	Serum		±20% or 0,2 mIU/L (greater)	1 CLIA, 2 WSLH, 3 CAP
Thyroid Stimulating Hormone (TSH)	Serum		±0,1 mU/L or 20% if > 0,5 mU/L	5 RCPA
Tobramycin	Serum		±20%	1 CLIA, 3 CAP
Tobramycin	Serum		±20%	2 WSLH
Tobramycin	Serum		±0,2 mg/L or 10% if > 2,0 mg/L	5 RCPA
Transferrin	Serum		±20%	3 CAP
Transferrin	Serum		±10%	4 AAB
Transferrin	Serum		±0,2 g/L or 8% if > 2,50 g/L	5 RCPA
Triglycerides	Serum		±15%	1 CLIA, 2 WSLH, 3 CAP
Triglycerides	Body Fluids		±25%	2 WSLH
Triglycerides	Serum		±25%	4 AAB
Triglycerides	Serum		±0,2 mmol/L or 12% if > 1,60 mmol/L	5 RCPA
Triglycerides	Body Fluids		±0,3 mmol/L or 25% if > 1,2 mmol/L	5 RCPA
Troponin I	Serum		±30% or 0,9 ng/mL (greater)	1 CLIA, 2 WSLH
Troponin I	Serum		±30%	4 AAB
Troponin I	Serum		±0,002 μg/L or 20% if > 0,010 μg/L	5 RCPA
Troponin I	Serum		±0,01 μg/L or 20% if > 0,05 μg/L	5 RCPA
Troponin T	Serum		±30% or 0,2 ng/mL (greater)	1 CLIA, 2 WSLH
Troponin T	Serum		±30%	4 AAB
Troponin T	Serum		±0,001 μg/L or 20% if > 0,050 μg/L	5 RCPA
Troponin T	Serum		±10 ng/L or 20% if > 50 ng/L	5 RCPA
Tryptase	Serum		±0,6 ug/L or 15% if > 4,0 ug/L	5 RCPA
Urate	Serum		±0,030 mmol/L or 8% if > 0,380 mmol/L	5 RCPA
Urate	Body Fluids		±0,06 mmol/L or 16% if > 0,38 mmol/L	5 RCPA
Urate	Urine		±0,3 mmol/L or 15% if > 2 mmol/L	5 RCPA
Urea Nitrogen (BUN)	Serum		±9% or 2 mg/dL (greater)	1 CLIA, 2 WSLH, 3 CAP, 4 AAB
Urea Nitrogen (BUN)	Urine		±10%	2 WSLH
Urea Nitrogen (BUN)	Serum		±0,5 mmol/L or 12% if > 4,0 mmol/L	5 RCPA
Urea Nitrogen (BUN)	Body Fluids		±1,0 mmol/L or 24% if > 4,0 mmol/L	5 RCPA
Urea Nitrogen (BUN)	Urine		±20 mmol/L or 10% if > 200 mmol/L	5 RCPA
Uric Acid	Serum		±10%	1 CLIA, 2 WSLH, 3 CAP
Uric Acid	Serum		±17%	4 AAB
Uric Acid	Urine		±17% or 2 mg/dL	2 WSLH
Valproate	Serum		±4,0 mg/L or 10% if > 36,0 mg/L	5 RCPA
Valproic Acid	Serum		±20%	1 CLIA, 2 WSLH, 3 CAP
Valproic Acid	Serum		±25%	4 AAB
Valproic Acid, Free	Serum		±3 SD or 10% (greater)	3 CAP
Vanadium	Serum		±1 nmol/L or 10% if > 10nmol/L	5 RCPA
Vanadium	Urine		±2 nmol/L or 10% if > 10nmol/L	5 RCPA
Vancomycin	Serum		±15% or 2 µg/mL (greater)	1 CLIA, 2 WSLH, 3 CAP
Vancomycin	Serum		±25% or 1,0 μg/mL (greater)	4 AAB
Vancomycin	Serum		±2,0 mg/L or 10% if > 20,3 mg/L	5 RCPA
Vitamin A	Serum		±0,2 μmol/L or 12% if > 1,7 μmol/L	5 RCPA
Vitamin B1	Serum		±9 nmol/L or 15% if > 60 nmol/L	5 RCPA
Vitamin B2	Serum		±25 nmol/L or 10% if > 250 nmol/L	5 RCPA
Vitamin B6	Plasma, WB		±9 nmol/L or 15% if > 60 nmol/L	5 RCPA
Vitamin B12	Serum		±25% or 30 pg/mL (greater)	1 CLIA, 2 WSLH
Vitamin B12	Serum		±25%	4 AAB
Vitamin B12	Serum		±18 pmol/L or 15% if > 120 pmol/L	5 RCPA
Vitamin C	Serum		±7 μmol/L or 20% if > 35 μmol/L	5 RCPA
Vitamin D3	Serum		±9 nmol/L or 15% if > 60 nmol/L	5 RCPA
Vitamin E	Serum		±3 μmol/L or 12% if > 25 μmol/L	5 RCPA
von Willebrand Activity	Plasma		±4% or 40% if > 10%	5 RCPA
von Willebrand factor, Antigen (vWF:Ag)	Plasma		±3% or 30% if > 10%	5 RCPA
von Willebrand Collagen binding (vWF:CB)	Plasma		±4% or 40% if > 10%	5 RCPA
von Willebrand Ristocetin Cofactor (vWF:rCo)	Plasma		±4% or 40% if > 10%	5 RCPA
Voriconazole	Serum		±0,2 mg/L or 10% if > 2,0 mg/L	5 RCPA
WBC, White Cell Count, Leukocyte count)	WB	automated differential	±10%	1 CLIA, 2 WSLH
WBC, White Cell Count, Leukocyte count)	WB		±15%	4 AAB
WBC, White Cell Count, Leukocyte count)	WB		±0.5x109/L or 10% if > 5,0 x109/L	5 RCPA
WBC Differential	WB		±3SD based on the percentage of different types of white blood cells in the samples	1 CLIA, 2 WSLH
WBC Differential	WB	automated differential	±3% or 30% if > 10%	5 RCPA
Zinc	Serum, Urine		±2 μmol/L or 10% if > 20,0 μmol/L	5 RCPA
Zinc	WB		±6 μmol/L or 10% if > 60 μmol/L	5 RCPA

Sources

Abbreviation	Source
1 CLIA	CLIA – Federal Register
2 WLSH	Wisconsin State Laboratory of Hygiene
3 CAP	College of American Pathologists
4 AAB	American Association of Bioanalysts
5 RCPA	The Royal College of Pathologists of Australasia and the Australasian Clinical Biochemist association Quality Assurance Program

Total Allowable Error Table (Prior to 20 juin24)

Analyte	Discipline	Fluid	Method	Limit	Source
11-Deoxycortisol	Unclassified			30 nmol/L, 15%	7 RCPA
11-Desoxycortisol	Unclassified	Serum		27,10%	5 BV
17-Hydroxyprogesterone	Unclassified			3 nmol/L, 20%	7 RCPA
17-Hydroxyprogesterone	Unclassified	Serum		30,20%	5 BV
5HIAA	Unclassified			20 umol/day, 20%	7 RCPA
5'-Hidroxiindolacetate - Concentration, 2	Unclassified	Urine		26,50%	5 BV
5'Nucleotidase	Unclassified	Serum		26,80%	5 BV
A/C Ratio	Unclassified			2,5 SD	2 WSLH
a1-Acid Glycoprotein	Unclassified	Serum		16,20%	5 BV
a1-Antichymotrypsin	Unclassified	Serum		16,80%	5 BV
a1-Antitrypsin	Unclassified	Serum		9,20%	5 BV
a1-Globulins	Unclassified	Serum		15,70%	5 BV
a1-Microglobulin - Concentration, first m	Unclassified	Urine		43,90%	5 BV
a2-Globulins	Unclassified	Serum		12,60%	5 BV
a2-Macroglobulin	Unclassified	Serum		7,60%	5 BV
a2-Microglobulin output, overnight	Unclassified	Urine		34,70%	5 BV
a-Amylase	Unclassified	Serum		15,70%	5 BV
a-Amylase (pancreatic)	Unclassified	Serum		17,70%	5 BV
a-Amylase concentration, random	Unclassified	Urine		103,70%	5 BV
Acetaminophen	Unclassified		Abbott AxSym	3 SD	4 CAP
Acetaminophen	Unclassified			2,5 mg/mL or 25%	6 AAB
Acetaminophen	Unclassified			+/- 15%	3 NYS
Acetaminophen	Unclassified			25%	2 WSLH
Acetaminophen	Unclassified			20%	8 CFX
Acetone	Unclassified			25%	2 WSLH
Acid Phosphatase	Unclassified			1,5 U/L & ug/L, 15%	7 RCPA
Acid Phosphatase	Unclassified	Serum		10,3	5 BV
Acid Phosphatase - Total	Unclassified			1,5 U/L & ug/L, 15%	7 RCPA
Acid phosphatase tartrate resistent	Unclassified	Serum		13,20%	5 BV
ACTH	Unclassified			2,0 pmol/L, 10%	7 RCPA
Activated Clotting Time	Unclassified			20%	6 AAB
Activated Clotting Time (ACT)	Unclassified			2 SD	2 WSLH
Activated Partial Thrombo Time	Unclassified			15%	6 AAB
Activated Partial Thromboplastine Time	Unclassified	Plasma		4,50%	5 BV
Active Renin	Unclassified			1,0 uU/mL, 25%	7 RCPA
Adenosine Deaminase	Unclassified	Serum		16,70%	5 BV
Adrenaline	Unclassified			50 nmol/day, 33%	7 RCPA
AFP	Unclassified			5 kIU/L, 20%	7 RCPA
AFP	Unclassified		Centaur	3 SD	4 CAP
AFP	Unclassified	Amniotic Fluid		+/- 3 SD	3 NYS
AFP	Unclassified	Maternal Sera		+/- 3 SD	3 NYS
AFP	Unclassified	Amniotic Fluid	Centaur	3 SD	4 CAP
AFPTM	Unclassified			+/- 3 SD	3 NYS
AFP-Tumor (Chiron)	Unclassified		Centaur	3 SD	4 CAP
Alanine Aminotransferase	Unclassified			35%	8 CFX
Alanine Aminotransferase	Unclassified			20%	6 AAB
Alanine Aminotransferase	Unclassified	Serum		32,10%	5 BV
Alanine Aminotransferase	Chimie			+/- 20%	1 CLIA, 2 WSLH, 3 NYS, 6 AAB
Alanine Aminotransferase	Unclassified			8 U/L, 15%	7 RCPA
Alanine Aminotransferase	Unclassified		AU640	20%	4 CAP
Alanine Transaminase	Unclassified			8 U/L, 15%	7 RCPA
Alanine Transaminase	Unclassified		AU640	20%	4 CAP
Albumin	Chimie			+/- 10%	1 CLIA, 2 WSLH, 3 NYS, 6 AAB
Albumin	Chimie		AU640	10%	4 CAP
Albumin	Chimie			10%	8 CFX
Albumin	Chimie	Serum		3,90%	5 BV
Albumin	Chimie			2,0 g/L, 10%	7 RCPA
Albumin	Unclassified	Cerebrospinal Fluid	BNII	20%	4 CAP
Albumin	Unclassified	Cerebrospinal Fluid		0,10 g/L, 10%	7 RCPA
Albumin	Unclassified	Urine		0,1 g/L, 10%	7 RCPA
Albumin	Unclassified	Blood	BNII	20%	4 CAP
Albumin - Concentration, first morning	Unclassified	Urine		46,10%	5 BV
Alcohol	Toxicologie	Blood		+/- 25%	1 CLIA, 2 WSLH, 6 AAB
Alcohol	Unclassified			2,2 mmol/L, 10%	7 RCPA
Alcohol	Unclassified	Blood		+/- 10%	3 NYS
Alcohol (Ethanol)	Unclassified	Urine		Pos/Neg	2 WSLH
Alcohol	Unclassified	Serum		25%	6 AAB
Aldosterone	Unclassified			75,0 pmol/L, 15%	7 RCPA
Aldosterone	Unclassified	Serum		36,70%	5 BV
Aldosterone - Concentration	Unclassified	Urine		39,60%	5 BV
Alkaline Phosphatase	Unclassified		AU640	30%	4 CAP
Alkaline Phosphatase	Chimie			+/- 30%	1 CLIA, 2 WSLH, 3 NYS, 6 AAB
Alkaline Phosphatase	Chimie	Serum		11,70%	5 BV
Alkaline Phosphatase	Unclassified			15 U/L, 15%	7 RCPA
Alkaline Phosphatase	Unclassified			30%	6 AAB
Alkaline Phosphatase	Unclassified			30%	8 CFX
Alkaline phosphatase, bone isoform	Unclassified	Serum		14,50%	5 BV
Alpha 1 Antitrypsin	Unclassified		BNII	3 SD	4 CAP
Alpha 1 Antitrypsin	Immunology			+/- 3 SD	1 CLIA, 3 NYS, 6 AAB
Alpha 1 Antitrypsin	Unclassified			3SD	6 AAB
Alpha fetoprotein (Prenatal screen)	Unclassified			3 SD	2 WSLH
Alpha-fetoprotein	Immunology			5 kIU/L, 20%	7 RCPA
Alpha-fetoprotein	Immunology			+/- 3 SD	1 CLIA, 2 WSLH
Amikacin	Unclassified			2,0 mg/L, 10%	7 RCPA
Amikacin	Unclassified			25%	2 WSLH
Amikacin	Unclassified			15%	8 CFX
Amiodarone	Unclassified			0,2 umol/L, 10%	7 RCPA
Amitriptyline	Unclassified			10 umol/L, 10%	7 RCPA
Amitriptyline	Unclassified			15%	8 CFX
Ammonia	Unclassified		AU640	not evaluated	4 CAP
Ammonia	Unclassified			3 umol/L, 10%	7 RCPA
Ammonia	Unclassified			2,5 SD	2 WSLH
Ammonia	Unclassified	Serum		10 umol/L or 5%	6 AAB
Ammonia - Output	Unclassified	Urine		29,60%	5 BV
Amphetamines	Unclassified		Abbott AxSym	80% consensus	4 CAP
Amphetamines	Unclassified			Pos/Neg	2 WSLH
Amphetamines	Unclassified			20% or 2 SD	3 NYS
Amphetamines - Qualitative	Unclassified			Presence or Absence	3 NYS
Amylase	Chimie			15 U/L, 15%	7 RCPA
Amylase	Chimie			+/- 30%	1 CLIA, 2 WSLH, 3 NYS, 6 AAB
Amylase	Chimie		AU640	30%	4 CAP
Amylase	Chimie			20%	8 CFX
Amylase	Unclassified	Urine		30%	2 WSLH
Amylase	Unclassified	Urine	AU640	3 SD	4 CAP
Androstenedione	Unclassified	Serum		22,60%	5 BV
Androstenedione	Unclassified			2,0 nmol/L	7 RCPA
Angiotensin converting enzyme	Unclassified	Plasma		17,90%	5 BV
Anti-CMV	Unclassified			Positive or Negative	3 NYS
Anti-Human Immunodeficiency virus	Immunology			Reaction or nonreactive	1 CLIA
Antinuclear antibody	Immunology			Target value +/- 2 dilution or (pos. or neg.)	1 CLIA, 3 NYS
Antistreptolysin O	Immunology			Target value +/- 2 dilution or (pos. or neg.)	1 CLIA, 3 NYS
Antithrombin III	Unclassified	Plasma		8,30%	5 BV
Apolipoprotein A1	Unclassified		BNII	3 SD	4 CAP
Apolipoprotein A1	Unclassified			25 mg/dL or 30%	6 AAB
Apolipoprotein A1	Unclassified			0,2 g/L, 10%	7 RCPA
Apolipoprotein A1	Unclassified	Serum		9,10%	5 BV
Apolipoprotein A1	Unclassified			10%	8 CFX
Apolipoprotein B	Unclassified		BNII	3 SD	4 CAP
Apolipoprotein B	Unclassified			20 mg/dL or 25%	6 AAB
Apolipoprotein B	Unclassified			0,2 g/L, 10%	7 RCPA
Apolipoprotein B	Unclassified			12%	8 CFX
Apolipoprotein B	Unclassified	Serum		11,60%	5 BV
Apolipoprotein B100	Unclassified		BNII	not evaluated	4 CAP
Ascorbic Acid	Unclassified	Serum		29,90%	5 BV
Aso-Antistreptolysin	Unclassified		BNII	2 SD	4 CAP
Aspartate Aminotransferase	Unclassified			20%	6 AAB
Aspartate Aminotransferase	Unclassified			20%	8 CFX
Aspartate Aminotransferase	Unclassified	Serum		15,20%	5 BV
Aspartate Aminotransferase	Chimie			+/- 20%	1 CLIA, 2 WSLH, 3 NYS, 6 AAB
a-Tocopherol	Unclassified	Serum		16,20%	5 BV
Automated Differential	Unclassified			3SD	6 AAB
b2-Microglobulin	Unclassified	Serum		9%	5 BV
Barbiturates	Unclassified			20% or 2 SD	3 NYS
Barbiturates	Unclassified		Abbott AxSym	80% consensus	4 CAP
Barbiturates	Unclassified			Pos/Neg	2 WSLH
Basophile, count	Unclassified	Serum		38,50%	5 BV
b-Carotene	Unclassified	Serum		43%	5 BV
Benzodiazepine	Unclassified		Abbott AxSym	80% consensus	4 CAP
Benzodiazepine	Unclassified			20% or 2 SD	3 NYS
Benzodiazepine	Unclassified			Pos/Neg	2 WSLH
Benzoylecgonine	Unclassified			20% or 2 SD	3 NYS
Beta 2 microglobulin	Unclassified			0,06 mg/L or 30%	6 AAB
Beta Carotene	Unclassified			0,2 umol/L, 10%	7 RCPA
Beta-2 Microglobulin	Unclassified			0,2 mg/L, 10%	7 RCPA
Beta-Hydroxybutyric Acid	Unclassified			2 SD	8 CFX
b-Globulins	Unclassified	Serum		11,70%	5 BV
Bicarbonate	Unclassified			2,0 mmol/L, 10%	7 RCPA
Bicarbonate (Total CO2)	Unclassified			4 mEq/L or 20%	6 AAB
Bilirubin - Direct	Unclassified			50%	8 CFX
Bilirubin - Direct	Unclassified		AU640	20% or 0,4 mg/dL (greater)	4 CAP
Bilirubin - Direct	Unclassified			0,4 mg/dL or 20%	2 WSLH
Bilirubin - Neonatal	Unclassified			31%	8 CFX
Bilirubin - Total	Unclassified			5 umol/L, 10%	7 RCPA
Bilirubin - Total	Unclassified			31%	8 CFX
Bilirubin - Total	Unclassified	Serum		31,10%	5 BV
Bilirubin - Total	Chimie			+/- 0,4 mg/dL or +/- 20% (greater)	1 CLIA, 2 WSLH, 3 NYS, 6 AAB
Bilirubin - Total	Unclassified		AU640	20% or 0,4 mg/dL (greater)	4 CAP
Bilirubin - Total	Unclassified			0,4 mg/dL or 20%	6 AAB
Bilirubin - Conjugated	Unclassified			10 umol/L, 20%	7 RCPA
Bilirubin - Conjugated	Unclassified	Serum		44,50%	5 BV
Bilirubin - Qualitative	Unclassified	Urine		80% Agreement	3 NYS
Bilirubin - Neonatal	Unclassified			0,4 mg/dL or 20%	2 WSLH
Blood gas p02	Chimie			+/- 3 SD	1 CLIA, 2 WSLH, 3 NYS, 6 AAB
Blood gas pCO2	Chimie			+/- 5 mm Hg or +/- 8% (greater)	1 CLIA, 2 WSLH, 3 NYS, 6 AAB
Blood gas pH	Chimie			+/- 0,04	1 CLIA, 2 WSLH, 3 NYS, 6 AAB
BNP	Unclassified		Centaur	not evaluated	4 CAP
BNP	Unclassified			5,0 pg/mL or 20%	6 AAB
BNP	Unclassified			2,0 SD	2 WSLH
BPb	Unclassified			+/-4 µg/dL (values <40µg/dL) or +/-10% (values >40µg/dL)	3 NYS
Bright CD45-/CD14+	Unclassified			3 SD	2 WSLH
C Peptide	Unclassified			1,0 nmol/L, 10%	7 RCPA
C Peptide	Unclassified	Serum		11,70%	5 BV
C3 Complement	Unclassified		BNII	3 SD	4 CAP
C3 Complement	Unclassified	Serum		8,40%	5 BV
C4 Complement	Unclassified		BNII	3 SD	4 CAP
C4 Complement	Unclassified	Serum		16%	5 BV
CA 125	Unclassified			2 SD	2 WSLH
CA 125	Unclassified			20 kU/L, 20%	7 RCPA
CA 125	Unclassified			+/- 3 SD	3 NYS
CA 125	Unclassified			9 U/mL or 30%	6 AAB
CA 125 Antigen	Unclassified	Serum		38,20%	5 BV
CA 15-3	Unclassified			2 SD	2 WSLH
CA 15-3 Antigen	Unclassified	Serum		15,50%	5 BV
CA 19-9	Unclassified			2 SD	2 WSLH
CA 19-9 Antigen	Unclassified	Serum		44,30%	5 BV
CA 549 antigen	Unclassified	Serum		16,20%	5 BV
CA15-3	Unclassified			3 kU/L, 15%	7 RCPA
CA15-3	Unclassified			+/- 3 SD	3 NYS
CA19-9	Unclassified			3 kU/L, 15%	7 RCPA
CA19-9	Unclassified			+/- 3 SD	3 NYS
CA27.29	Unclassified			+/- 3 SD	3 NYS
Caffeine	Unclassified			15%	8 CFX
Calcitonin	Unclassified			2 ng/L, 10%	7 RCPA
Calcium	Unclassified	Urine		1,0 mg/dL	6 AAB
Calcium	Unclassified			1,0 mg/dL	6 AAB
Calcium	Unclassified		AU640	1 mg/dL	4 CAP
Calcium	Unclassified			0,10 mmol/L	7 RCPA
Calcium	Unclassified			8%	8 CFX
Calcium	Unclassified	Serum		2,40%	5 BV
Calcium	unclassified	Urine		1 mg/dL	2 WSLH
Calcium	Unclassified	Urine	AU640	31%	4 CAP
Calcium	Unclassified	Urine		0,20 mmol/L	7 RCPA
Calcium - Ionized	Unclassified			10%	8 CFX
Calcium - Ionized	Unclassified		Radiometer 725	3 SD	4 CAP
Calcium - Ionized	Unclassified	Urine		2,10%	5 BV
Calcium - Concentration, 24h	Unclassified	Urine		34,10%	5 BV
Calcium - Output, 24h	Unclassified	Urine		31%	5 BV
Calcium - Total	Chimie			+/- 1,0 mg/dL	1 CLIA
Cannabinoid	Unclassified		Abbott AxSym	80% consensus	4 CAP
Cannabinoid	Unclassified			Pos/Neg	2 WSLH
Carbamazepine	Toxicologie			2,0 umol/L, 10%	7 RCPA
Carbamazepine	Toxicologie			+/- 25%	1 CLIA, 2 WSLH, 6 AAB
Carbamazepine	Toxicologie			+/- 15%	3 NYS
Carbamazepine	Toxicologie		Abbott AxSym	25%	4 CAP
Carbamazepine	Toxicologie			25%	8 CFX
Carbamazepine, free	Unclassified		TDX	3 SD	4 CAP
Carbohydrate deficient transferrin	Unclassified	Serum		15,70%	5 BV
Carbon Dioxide	Unclassified			5,0 mmol/L	2 WSLH
Carboxyhemoglobin	Unclassified			3 SD	2 WSLH
Carboxyhemoglobin	Unclassified		Radiometer 725	3 SD	4 CAP
Carcinoembryonic Antigen	Unclassified			1,2 ng/mL or 30%	6 AAB
Carcinoembryonic Antigen	Unclassified	Serum		21,80%	5 BV
CD19+	Unclassified			3 SD	2 WSLH
CD2+	Unclassified			3 SD	2 WSLH
CD20+	Unclassified			3 SD	2 WSLH
CD3-/CD16+56+	Unclassified			3 SD	2 WSLH
CD3+	Unclassified			3 SD	2 WSLH
CD3+/CD4+	Unclassified			3 SD	2 WSLH
CD3+/CD8+	Unclassified			3 SD	2 WSLH
CD4+	Unclassified			3 SD	2 WSLH
CD5+	Unclassified			3 SD	2 WSLH
CD8+	Unclassified			3 SD	2 WSLH
CEA	Unclassified		Abbott AxSym	3 SD	4 CAP
CEA	Unclassified			2,0 ug/L, 20%	7 RCPA
CEA	Unclassified			1,2 ng/mL or 30%	2 WSLH
CEA	Unclassified			+/- 3 SD	3 NYS
Cell Identification	Hématologie			90% or greater consensus on identification	1 CLIA, 3 NYS
Ceruloplasmin	Unclassified		BNII	3 SD	4 CAP
Ceruloplasmin	Unclassified	Serum		7,80%	5 BV
Chloride	Chimie			3,0 mmol/L	7 RCPA
Chloride	Chimie			+/- 5%	1 CLIA, 2 WSLH, 3 NYS, 6 AAB
Chloride	Chimie		Radiometer 725	5%	4 CAP
Chloride	Chimie		AU640	5%	4 CAP
Chloride	Chimie			5%	8 CFX
Chloride	Chimie	Serum		1,50%	5 BV
Chloride	Unclassified	Urine		5%	2 WSLH
Chloride	Unclassified	Urine	AU640	3 SD	4 CAP
Chloride	Unclassified	Sweat		2 mmol/L, 10%	7 RCPA
Chloride	Unclassified	Urine		2,0 mmol/L, 10%	7 RCPA
Cholesterol	Unclassified			0,50 mmol/L, 5%	7 RCPA
Cholesterol	Unclassified		AU640	10%	4 CAP
Cholesterol	Unclassified	Serum		9%	5 BV
Cholesterol - HDL	Unclassified			11%	8 CFX
Cholesterol - HDL	Chimie			+/- 30%	1 CLIA, 2 WSLH, 3 NYS, 6 AAB
Cholesterol - HDL	Unclassified
Cholesterol - HDL	Unclassified			0,20 mmol/L, 10%	7 RCPA
Cholesterol - HDL	Unclassified			30%	6 AAB
Cholesterol - HDL	Unclassified	Serum		11,10%	5 BV
Cholesterol - HDL	Unclassified		AU640	30%	4 CAP
Cholesterol - LDL	Unclassified			15%	8 CFX
Cholesterol - LDL	Unclassified			Non-graded analyte	3 NYS
Cholesterol - LDL	Unclassified			30%	2 WSLH
Cholesterol - Total	Unclassified			9%	8 CFX
Cholesterol - Total	Unclassified			10%	6 AAB
Cholesterol - Total	Chimie			+/- 10%	1 CLIA, 2 WSLH, 3 NYS, 6 AAB
Cholinesterase	Unclassified	Serum		8,90%	5 BV
Cholinesterase, catalitic activity	Unclassified	Serum		7,40%	5 BV
CK2 Isoenzyme (CKMB)	Unclassified			3SD	6 AAB
CO2	Unclassified		AU640	3 SD	4 CAP
CO2 - Total	Unclassified			20%	8 CFX
Cocaine-Metabolite	Unclassified			Pos/Neg	2 WSLH
Cocaine-Metabolite	Unclassified		Abbott AxSym	80% consensus	4 CAP
Complement C3	Immunology			+/- 3 SD	1 CLIA, 3 NYS, 6 AAB
Complement C4	Immunology			+/- 3 SD	1 CLIA, 3 NYS, 6 AAB
Conjugated Bilirubin, Neonatal	Unclassified			10 umol/L, 20%	7 RCPA
Copper	Unclassified	Plasma		11,80%	5 BV
Copper	Unclassified	Serum		7,70%	5 BV
Cortisol	Endocrinology			30 nmol/L, 15%	7 RCPA
Cortisol	Endocrinology			+/- 25%	1 CLIA, 2 WSLH, 3 NYS, 6 AAB
Cortisol	Endocrinology			30%	8 CFX
Cortisol	Endocrinology	Serum		29,80%	5 BV
Cortisol	Endocrinology		Centaur	25%	4 CAP
C-Propeptide type I procollagen	Unclassified	Serum		11,60%	5 BV
cPSA	Unclassified			+/- 3 SD	3 NYS
C-Reactive protein	Unclassified	Serum		68,30%	5 BV
Creatine Kinase	Chimie			+/- 30%	1 CLIA, 2 WSLH, 3 NYS, 6 AAB
Creatine Kinase	Chimie	Serum		30,30%	5 BV
Creatine Kinase	Unclassified			15 U/L, 15%	7 RCPA
Creatine Kinase	Unclassified			30%	6 AAB
Creatine Kinase	Unclassified			30%	8 CFX
Creatine Kinase isoenzymes	Chimie			MB elevated (present or absent) or Target value +/- 3 SD	1 CLIA, 2 WSLH, 3 NYS, 6 AAB
Creatine Kinase MB	Unclassified			6 U/L & ug/L, 15%	7 RCPA
Creatine Kinase MB	Unclassified		Centaur	3 SD	4 CAP
Creatine Kinase MB, %	Unclassified	Serum		16,50%	5 BV
Creatine Kinase MB, activity	Unclassified			40%	8 CFX
Creatine Kinase MB, activity	Unclassified	Serum		24,10%	5 BV
Creatine Kinase MB, mass	Unclassified			2 SD	8 CFX
Creatine Kinase MB, mass	Unclassified	Serum		31,20%	5 BV
Creatine Kinase MB, qualitative	Unclassified			Pos/Neg	2 WSLH
Creatine Kinase, Total	Unclassified		AU640	30%	4 CAP
Creatinine	Chimie		AU640	15% or 0,3 mg/dL (greater)	4 CAP
Creatinine	Chimie			0,01 mmol/L, 10%	7 RCPA
Creatinine	Chimie			+/- 0,3 mg/dL or +/- 15% (greater)	1 CLIA, 2 WSLH, 3 NYS, 6 AAB
Creatinine	Chimie			25%	8 CFX
Creatinine	Chimie	Serum		6,90%	5 BV
Creatinine	Unclassified	Urine	AU640	17%	4 CAP
Creatinine	Unclassified	Urine		0,5 mmol/L, 10%	7 RCPA
Creatinine	Unclassified	Urine		3 mg/dL or 15%	6 AAB
Creatinine - Quantitative	Unclassified	Urine		0,3 mg/dL or 17%	2 WSLH
Creatinine - Semi Quantitative	Unclassified	Urine			2 WSLH
Creatinine Clearence	Unclassified	Patient-		16%	5 BV
Creatinine - Concentration	Unclassified	Urine		28,40%	5 BV
Creatinine - Output	Unclassified	Urine		15,40%	5 BV
CRP	Unclassified		BNII	2 SD	4 CAP
CRP	Unclassified			0,4 mg/dL or 3 SD%	6 AAB
Cryptococcus neoformans Antigen	Unclassified			Positive or Negative or +/- 2 dilutions	3 NYS
CSF Protein	Unclassified		AU640	2 SD	4 CAP
C-Telopeptide type I procollagen	Unclassified	Serum		14,10%	5 BV
Cyclosporine	Unclassified		TDX	3 SD	4 CAP
Cystein	unclassified	Plasma		8,30%	5 BV
d-Dimer	Unclassified			30%	6 AAB
d-Dimer - Interpretation	Unclassified			Pos/Neg	2 WSLH
d-Dimer - Quantitative	Unclassified			2 SD	2 WSLH
d-Dimer - Semi Quantitative	unclassified			Pos/Neg	2 WSLH
Dehydroepiandrosterone sulfate	Unclassified	Serum		22,20%	5 BV
Deoxipyridinoline/creatinine, 24h	Unclassified	Urine		21,20%	5 BV
Deoxipyridinoline/creatinine, morning sp	Unclassified	Urine		33%	5 BV
Desipramine	Unclassified			15%	8 CFX
DHEA Sulfate	Unclassified			2,5 SD	2 WSLH
DHEA Sulphate	Unclassified			2 SD	8 CFX
DHEA Sulphate	Unclassified			1,0 umol/L, 10%	7 RCPA
Digoxin	Toxicologie		Centaur	20% or 0,2 ng/mL (greater)	4 CAP
Digoxin	Toxicologie			15% or 0,2 ng/mL	3 NYS
Digoxin	Toxicologie			0,2 nmol/L, 10%	7 RCPA
Digoxin	Toxicologie			+/- 20% or 0,2 ng/mL (greater)	1 CLIA, 2 WSLH, 6 AAB
Digoxin	Toxicologie			25%	8 CFX
Dipeptidyl-peptidase IV	Unclassified	Plasma		10,90%	5 BV
Direct Bilirubin	Unclassified			0,4 mg/dL or 20%	6 AAB
Disopyramide	Unclassified			2,0 umol/L, 10%	7 RCPA
Disopyramide	Unclassified			15%	8 CFX
DMF	Unclassified			0,45 mmol/L or 30%	6 AAB
Dopamine	Unclassified			0,25 umol/day, 25%	7 RCPA
DPD - Free	Unclassified	Urine		15 nmol/L, 15%	7 RCPA
DPD - Total	Unclassified	Urine		15 nmol/L, 15%	7 RCPA
Elastase-Pl	Unclassified	Plasma		16,50%	5 BV
Eosinophils, count	Unclassified	Blood		37,10%	5 BV
EP	Unclassified			+/-6 µg/dL (values <40µg/dL) or +/-15% (values >40µg/dL)	3 NYS
Erythrocites, count	Unclassified	Blood		4,40%	5 BV
Erythrocites, count	Hématologie			+/- 6%	1 CLIA, 2 WSLH, 3 NYS, 6 AAB
Erythrocyte Sedimentation Rate (ESR)	Unclassified			3SD	6 AAB
Erythrocyte Sedimentation Rate (ESR) - Rapid	Unclassified			3SD	6 AAB
Erythrocytes	Unclassified			6%	6 AAB
Estradiol	Unclassified			3 pg/mL or 30%	6 AAB
Estradiol	Unclassified			3 ng/mL or 30%	2 WSLH
Estradiol	Unclassified			2 SD	8 CFX
Estradiol	Unclassified			+/-25% or 30 pg/mL	3 NYS
Estradiol	Unclassified	Urine		27%	5 BV
Estriol	Unclassified			2,5 SD	2 WSLH
Estriol - Total	Unclassified			2 SD	8 CFX
Estriol - Unconjugated	Unclassified			2 SD	8 CFX
Estrogen	Unclassified			2,5 SD	2 WSLH
Ethanol	Unclassified		Abbott AxSym	80% consensus	4 CAP
Ethanol	Unclassified	Urine	HP GLC	25% or 9 mg/dL (greater)	4 CAP
Ethanol	unclassified			20% or 2 SD	3 NYS
Ethanol	Unclassified	Blood	HP GLC	25%	4 CAP
Ethanol	Unclassified			15%	8 CFX
Ethosuximide	Toxicologie			3 umol/L, 10%	7 RCPA
Ethosuximide	Toxicologie			+/- 20%	1 CLIA, 2 WSLH
Ethosuximide	Toxicologie			+/- 15%	3 NYS
Ethosuximide	Toxicologie			15%	8 CFX
Factor VII coagulation	Unclassified	Plasma		0,107	5 BV
Factor VIII coagulation	Unclassified	Plasma		0,089	5 BV
Faecal Percent Dry Weight	Unclassified			1, 10%	7 RCPA
Faecal Total Porphyrin	Unclassified			15 umol/kg, 15%	7 RCPA
Fentanyl	Unclassified			20% or 2 SD	3 NYS
Ferritin	Unclassified			6,0 ug/L, 15%	7 RCPA
Ferritin	unclassified			4,5 ng/mL or 30%	2 WSLH
Ferritin	Unclassified			4,5 ng/mL or 30%	6 AAB
Ferritin	Unclassified		Centaur	3 SD	4 CAP
Ferritin	Unclassified			19,30%	8 CFX
Ferritine	unclassified	Serum		17,30%	5 BV
Fibrinogen	Hématologie			+/- 20%	1 CLIA, 2 WSLH, 3 NYS, 6 AAB
Fibrinogen	Hématologie	Plasma		13,60%	5 BV
Folate	Unclassified	Serum	Centaur	3 SD	4 CAP
Folate	Unclassified			2 SD	8 CFX
Folate	Unclassified			1,0 umol/day, 30%	7 RCPA
Folate	Unclassified			0,9 ng/mL or 30%	2 WSLH
Folate	Unclassified			0,9 ng/mL or 30%	6 AAB
Folate	Unclassified	Serum		39%	5 BV
Folate	Unclassified	Blood-Erythrocytes		26,70%	5 BV
Folic Acid	Unclassified			+/- 30% or 2,0 ng/mL	3 NYS
Follicle Stimulating Hormone (FSH)	Unclassified			2 SD	8 CFX
Follicle Stimulating Hormone (FSH)	Unclassified	Serum		16,70%	5 BV
Follicle Stimulating Hormone (FSH)	Unclassified			2 mIU/mL or 25%	6 AAB
fPSA	Unclassified			+/- 3 SD	3 NYS
Fractional Carboxyhemoglobin	Unclassified			0,02	7 RCPA
Fractional Methemoglobin	Unclassified			1,0, 10%	7 RCPA
Fractional Oxyhemoglobin	Unclassified			3, 4%	7 RCPA
Free Estriol	Unclassified			+/-25% or 3,0 ng/mL	3 NYS
Free phenytoin	Unclassified			+/- 20%	3 NYS
Free PSA	Unclassified			1,5 ug/L, 15%	7 RCPA
Free T3	Unclassified			3,0 pmol/L	7 RCPA
Free T3	Unclassified			3 SD	2 WSLH
Free T4 (Endocrinology)	Endocrinology			1,5 pmol/L, 15%	7 RCPA
Free T4 (General Chemistry)	Chimie			3 pmol/L, 15%	7 RCPA
Free thyroxine	Endocrinology			+/- 3 SD	1 CLIA, 2 WSLH, 3 NYS
Free thyroxine (FT4)	Unclassified	Serum		9,90%	5 BV
Fructosamine	Unclassified			30 umol/L, 10%	7 RCPA
Fructosamine	Unclassified	Serum		4,50%	5 BV
Follicle Stimulating Hormone (FSH)	Unclassified			4,0 IU/L, 20%	7 RCPA
Follicle Stimulating Hormone (FSH)	Unclassified		Centaur	3 SD	4 CAP
Follicle Stimulating Hormone (FSH)	Unclassified			2 mIU/mL or 25%	2 WSLH
Follicle Stimulating Hormone (FSH)	Unclassified			+/-25%	3 NYS
Galactosy hydroxylisine	Unclassified	Serum		16,80%	5 BV
Gamma-Glutamyl Transferase	Unclassified			+/- 30%	3 NYS
Gamma-Glutamyl Transferase	Unclassified			20%	2 WSLH
Gamma-Glutamyl Transferase	Unclassified			30%	8 CFX
Gamma-Glutamyl Transferase	unclassified			10 IU/L or 20%	6 AAB
Gamma-Glutamyl Transferase	Unclassified	Serum		22,20%	5 BV
Gamma-Glutamyl Transferase	Unclassified			8 U/L, 15%	7 RCPA
Gamma-Glutamyl Transferase	Unclassified		AU640	3 SD	4 CAP
Gastrin	Unclassified			25 pmol/L, 10%	7 RCPA
Gentamicin	Toxicologie			0,5 mg/L, 10%	7 RCPA
Gentamicin	Toxicologie			+/- 25%	1 CLIA, 2 WSLH, 6 AAB
Gentamicin	Toxicologie			+/- 15%	3 NYS
Gentamicin	Toxicologie		Abbott AxSym	25%	4 CAP
Gentamicin	Toxicologie			20%	8 CFX
g-Globulins	Unclassified	Serum		16,80%	5 BV
Globulins, total	Unclassified	Serum		8%	5 BV
Glucose	Chimie		Radiometer 725	10% or 6 mg/dL (greater)	4 CAP
Glucose	Chimie		AU640	10% or 6 mg/dL (greater)	4 CAP
Glucose	Chimie			0,5 mmol/L, 10%	7 RCPA
Glucose	Chimie			+/- 6 mg/dL or +/- 10% (greater)	1 CLIA, 2 WSLH, 3 NYS, 6 AAB
Glucose	Chimie	Serum		6,30%	5 BV
Glucose	Unclassified	Urine		10%	2 WSLH
Glucose	Unclassified	Cerebrospinal Fluid		10%	2 WSLH
Glucose	Unclassified	Whole Blood		20 mg/dL or 20%	2 WSLH
Glucose	Unclassified	Gazométrie sanguine		1,0 mmol/day, 10%	7 RCPA
Glucose	Unclassified	Cerebrospinal Fluid		1,0 mmol/L, 10%	7 RCPA
Glucose	Unclassified	Urine		1,0 mmol/L, 10%	7 RCPA
Glucose	Unclassified	Urine	AU640	10% or 6 g/24 hs (greater)	4 CAP
Glucose	Unclassified			0,3 mmol/L, 8,0%	8 CFX
Glucose	Unclassified	Whole Blood		6 mg/dL or 10%	6 AAB
Glucose - Qualitative	Unclassified	Urine		80% Agreement	3 NYS
Glucose-6-phosphate-1-dehydrogenase	Unclassified	Blood-Erythrocytes		38,50%	5 BV
Glutathione Peroxidase	Unclassified	Serum		11,70%	5 BV
Glycated Albumin	Unclassified	Serum		7,20%	5 BV
Glycated Hemoglobin A1c	Unclassified			9%	8 CFX
Glycated total protein	Unclassified	Serum		3,70%	5 BV
Glycohemoglobin	Unclassified			1,00% or 25%	6 AAB
Growth Hormone	Unclassified			2 mU/L, 20%	7 RCPA
Haptoglobin	Unclassified		BNII	not evaluated	4 CAP
Haptoglobin	Unclassified	Plasma or Serum		27,30%	5 BV
hCG	Unclassified			32%	8 CFX
hCG	Unclassified	Maternal Sera		+/- 3 SD	3 NYS
hCG - Quantitative	Unclassified		Centaur	3 SD	4 CAP
hCG - Qualitative	Unclassified	Serum		Pos/Neg	2 WSLH
hCG - Quantitative	Unclassified			3,0 IU/L, 15%	7 RCPA
hCG - Quantitative	Unclassified	Urine		5 IU/L, 10%	7 RCPA
HDL 1 cholesterol	Unclassified	Serum		11,50%	5 BV
HDL 2 cholesterol	Unclassified	Serum		23,90%	5 BV
HDL 3 cholesterol	Unclassified	Serum		9,80%	5 BV
Hematocrit	Hématologie			+/- 6%	1 CLIA, 2 WSLH, 3 NYS, 6 AAB
Hematocrit	Hématologie	Blood		4,10%	5 BV
Hemoglobin	Hématologie			+/- 7%	1 CLIA, 2 WSLH, 3 NYS, 6 AAB
Hemoglobin	Hématologie	Blood		4,10%	5 BV
Hemoglobin A1c	Unclassified	Serum		4,40%	5 BV
Hemoglobin A1c	Unclassified			1,0 or 25%	2 WSLH
Hemoglobin A1c	Unclassified			0,5, 5%	7 RCPA
Hemoglobin concentration	Unclassified			3 g/L, 3%	7 RCPA
Hemoglobin - Qualitative	Unclassified	Urine		80% Agreement	3 NYS
Hemoglobin - Total	Unclassified			7%	2 WSLH
Hemoglobin,Total A1	Unclassified			1,0 or 25%	2 WSLH
Hepatitis (Anti-HBc HBsAg HBeAg Anti-HCV )	Unclassified			Reactive (Positive) or Nonreactive (Negative)	3 NYS
Hepatitis (HBsAg, anti-HBc, HBeAg)	Immunology			Reactive (positive) or nonreactive (negative)	1 CLIA
Heterophile	unclassified			Positive or Negative or +/- 2 dilutions	3 NYS
high sensitivity CRP	Unclassified			0,4 mg/L or 3 SD%	6 AAB
high sensitivity CRP	Unclassified		BNII	not evaluated	4 CAP
high sensitivity CRP	Unclassified			2,0 SD	2 WSLH
HMMA	Unclassified			20 umol/day, 20%	7 RCPA
Homocysteine	Unclassified			Non-graded analyte	3 NYS
Homocysteine	Unclassified		IMX	3 SD	4 CAP
Homocysteine	Unclassified			2,5 umol/L or 20%	6 AAB
Homocysteine	Unclassified	Plasma		17,70%	5 BV
Homocysteine	Unclassified			15%	8 CFX
Human Chorionic Gonadotropin	Endocrinology			+/- 3 SD or (positive or negative)	1 CLIA, 2 WSLH, 3 NYS, 6 AAB
Human Chorionic Gonadotropin	Unclassified			3SD	6 AAB
HVA	Unclassified			8 umol/day, 25%	7 RCPA
Hydroxiproline/creatinine	Unclassified	Serum		32,90%	5 BV
Hydroxiproline/minute, night	Unclassified	Urine		0,43%	5 BV
Hydroxyproline	Unclassified	Urine		10 umol/L, 10%	7 RCPA
IBC - Total	Unclassified			25%	8 CFX
IBC - Unsaturated	Unclassified			2 SD	8 CFX
IgA	Immunology			+/- 3 SD	1 CLIA, 3 NYS, 6 AAB
IgA	Unclassified	Blood	BNII	3 SD	4 CAP
IgB	Immunology			+/- 3 SD	1 CLIA
IgE	Unclassified			4,0 IU/L, 20%	7 RCPA
IgE	Unclassified	Opt		3SD	6 AAB
IgE	Unclassified			3SD	6 AAB
IgE	Unclassified			+/- 3 SD	3 NYS
IGF-1	Unclassified			3 nmol/L, 15%	7 RCPA
IgG	Immunology			+/- 25%	1 CLIA, 3 NYS, 6 AAB
IgG	Unclassified	Blood	BNII	3 SD	4 CAP
IgG	Unclassified	Cerebrospinal Fluid	BNII	3 SD	4 CAP
IgG	Unclassified	Blood	BNII	25%	4 CAP
IgM	Immunology			+/- 3 SD	1 CLIA, 3 NYS, 6 AAB
IgM	Unclassified	Blood	BNII	3 SD	4 CAP
Imipramine	Unclassified			15%	8 CFX
Immunofix	Unclassified	Urine	Sebia Hydrasis LS	90% consensus	4 CAP
Immunofixation	Unclassified	Serum	Sebia Hydrasis LS	90% consensus	4 CAP
Immunoglobin G	Unclassified	Cerebrospinal Fluid		0,1 g/L, 10%	7 RCPA
Immunoglobulin A	Unclassified	Serum		13,50%	5 BV
Immunoglobulin G	Unclassified	Serum		8%	5 BV
Immunoglobulin M	Unclassified	Serum		16,80%	5 BV
Immunoglobulins K chain	Unclassified	Serum		8%	5 BV
Immunoglobulins l chain	Unclassified	Serum		8,60%	5 BV
Infectious mononucleosis	Immunology			Target value +/- 2 dilution or (pos. or neg.)	1 CLIA
INR	Unclassified			2 SD	2 WSLH
Insulin	Unclassified			5 mU/L, 25%	7 RCPA
Insulin	Unclassified			+/-25% or 3,0 uU/mL	3 NYS
Insulin	Unclassified	Serum		32,90%	5 BV
Interferon receptor	Unclassified	Blood-Leukocyte		17,70%	5 BV
Interleukin-1B	Unclassified	Serum		36,50%	5 BV
Interleukin-8	Unclassified	Serum		29,60%	5 BV
Ionised Calcium	Unclassified			0,05 mmol/L	7 RCPA
Ionized Calcium	Unclassified			0,25 mmol/L	6 AAB
Ionized Calcium	Unclassified			0,13 mmol/L	2 WSLH
Iron	Unclassified			5 umol/L	7 RCPA
Iron	Unclassified			31%	8 CFX
Iron	Unclassified	Blood-Leukocyte		30,70%	5 BV
Iron	Unclassified		AU640	20%	4 CAP
Iron	Unclassified			20%	6 AAB
Iron Binding Capacity	Unclassified			20%	2 WSLH
Iron Binding Capacity	Unclassified		AU640	20%	4 CAP
Iron Saturation	Unclassified		Calculated	3 SD	4 CAP
Iron, total	Chimie			+/- 20%	1 CLIA, 2 WSLH, 3 NYS, 6 AAB
Isopropanol	Unclassified		HP GLC	not evaluated	4 CAP
Ketones - Qualitative	Unclassified	Urine		80% Agreement	3 NYS
Lactate	Unclassified		AU640	2 SD	4 CAP
Lactate	Unclassified			1,0 mmol/L, 10%	7 RCPA
Lactate	Unclassified			1,0 mmol/day, 10%	7 RCPA
Lactate	Unclassified			0,2 mmol/L or 2SD	2 WSLH
Lactate	Unclassified	Blood		30,40%	5 BV
Lactate	Unclassified			3%	8 CFX
Lactate	Unclassified		Radiometer 725		4 CAP
Lactate	Unclassified	Cerebrospinal Fluid		0,1 mmol/L, 10%	7 RCPA
Lactate Dehydrogenase (LDH)	Unclassified			30 U/L, 15%	7 RCPA
Lactate Dehydrogenase (LDH)	Unclassified		AU640	20%	4 CAP
Lactate Dehydrogenase (LDH)	Unclassified			20%	6 AAB
Lactate Dehydrogenase (LDH)	Unclassified			20%	8 CFX
Lactate Dehydrogenase (LDH)	Chimie			+/- 20%	1 CLIA, 2 WSLH, 3 NYS, 6 AAB
Lactate Dehydrogenase (LDH)	Chimie	Serum		0,114	5 BV
Lactate dehydrogenase 1 isoform (LDH1)	Unclassified	Serum		8,20%	5 BV
Lactate dehydrogenase 2 isoform (LDH2)	Unclassified	Serum		5,70%	5 BV
Lactate dehydrogenase 3 isoform (LDH3)	Unclassified	Serum		5,80%	5 BV
Lactate dehydrogenase 4 isoform (LDH4)	Unclassified	Serum		11%	5 BV
Lactate dehydrogenase 5 isoform (LDH5)	Unclassified	Serum		14,80%	5 BV
Lactoferrin	Unclassified	Opt		0,5 mg/mL or 20%	6 AAB
Lactoferrin	Unclassified	Plasma		16,40%	5 BV
LD Isoenzymes 3-5	Unclassified			3,00% or 30%	6 AAB
LDH isoenzymes	Chimie			LDH1/LDH2 (+ or -) or Target value +/- 30%	1 CLIA, 3 NYS
LDL Cholesterol	Unclassified	Serum		13,60%	5 BV
LDL- Cholesterol	Unclassified		AU640	20%	4 CAP
LDL Cholesterol - Direct	Unclassified			15 mg/dL or 20%	6 AAB
LDL receptor mRNA	Unclassified	Serum		24,10%	5 BV
Lead	Toxicologie	Blood		+/- 10% or +/- 4 mcg/dL (greater)	1 CLIA, 2 WSLH
Lead	Unclassified	Blood	Spectra AA	10% or 4 ug/dL (greater)	4 CAP
Leukocytes	Unclassified			15%	6 AAB
Leukocytes, count	Hématologie			+/- 15%	1 CLIA
Leukocytes, count	Unclassified	Plasma		14,60%	5 BV
Luteinizing Hormone (LH)	Unclassified		Centaur	3 SD	4 CAP
Luteinizing Hormone (LH)	Unclassified			2,5 SD	2 WSLH
Luteinizing Hormone (LH)	Unclassified			2,0 IU/L, 20%	7 RCPA
Luteinizing Hormone (LH)	Unclassified			+/-25% or 1,5 IU/L	3 NYS
Lignocaine	Unclassified			2,0 umol/L, 10%	7 RCPA
Lipase	Unclassified			40 U/L, 20%	7 RCPA
Lipase	Unclassified			37%	8 CFX
Lipase	Unclassified			30%	2 WSLH
Lipase	Unclassified		AU640	30%	4 CAP
Lipase	Unclassified			30%	6 AAB
Lipase	Unclassified	Serum		29,10%	5 BV
Lipoprotein (a)	Unclassified			2 SD	8 CFX
Lipoprotein (a)	Unclassified			10 mg/dL or 30%	6 AAB
Lipoprotein (a)	Unclassified	Serum		28,80%	5 BV
Lithium	Toxicologie		AVL 9180	20% or 0,3 mEq/L (greater)	4 CAP
Lithium	Toxicologie			0,2 mmol/L	7 RCPA
Lithium	Toxicologie			+/- 20% or 0,3 mmol/L	1 CLIA, 2 WSLH, 6 AAB
Lithium	Toxicologie			+/- 15% or 0,3 mmol/L	3 NYS
Lithium	Toxicologie			10%	8 CFX
Luteinizing Hormone (LH)	Unclassified			2 SD	8 CFX
Luteinizing Hormone (LH)	Unclassified			2 mIU/mL or 25%	6 AAB
Luteinizing Hormone (LH)	Unclassified	Serum		19,80%	5 BV
Lymphocytes, count	Unclassified	Blood		16%	5 BV
Magnesium	Chimie			3 mmol/L	7 RCPA
Magnesium	Chimie			0,1 mmol/L, 12%	8 CFX
Magnesium	Chimie			+/- 25%	1 CLIA, 2 WSLH, 3 NYS, 6 AAB
Magnesium	Chimie	Blood-Leukocyte		21,20%	5 BV
Magnesium	Chimie	Blood-Erythrocytes		7,80%	5 BV
Magnesium	Chimie	Serum		4,80%	5 BV
Magnesium	Unclassified		AU640	25%	4 CAP
Magnesium	Unclassified	Urine		25%	2 WSLH
Magnesium	Unclassified	Urine	AU640	25%	4 CAP
Magnesium - Ionized	Unclassified			10%	8 CFX
Magnesium (serum)	Unclassified	Urine		0,12 mmol/L	7 RCPA
Magnesium - Concentration, 24h	Unclassified	Urine		52,20%	5 BV
Magnesium, ionized	Unclassified	Urine		2,90%	5 BV
Magnesium - Output, 24h	Unclassified	Urine		45%	5 BV
Mean corpuscular hemoglobin (HCM)	Unclassified	Blood-Erythrocytes		2,70%	5 BV
Mean corpuscular hemoglobin concentration	Unclassified	Blood-Erythrocytes		2,20%	5 BV
Mean corpuscular volume (MCV)	Unclassified			3 SD	2 WSLH
Mean corpuscular volume (MCV)	Unclassified	Blood-Erythrocytes		2,30%	5 BV
Mean platelet volume (MPV)	Unclassified	Blood-Platelets		5,80%	5 BV
Metanephrine	Unclassified			0,5 umol/day, 33%	7 RCPA
Methadone	Unclassified			Pos/Neg	2 WSLH
Methadone	Unclassified			20% or 2 SD	3 NYS
Methanol	Unclassified		HP GLC	not evaluated	4 CAP
Methemoglobin	Unclassified			3 SD	2 WSLH
Methemoglobin	Unclassified		Radiometer 725	2%	4 CAP
Methotrexate	Unclassified			0,1 umol/L, 10%	7 RCPA
Methotrexate	Unclassified			25%	8 CFX
Methqualone	Unclassified			Pos/Neg	2 WSLH
Microalbumin	Unclassified	Urine	AU640	3 SD	4 CAP
Microalbumin	Unclassified	Urine		10 mg/L or 25%	6 AAB
Microalbumin - Quantitative	Unclassified			2,5 SD	2 WSLH
Monocytes, count	Unclassified	Blood		27,90%	5 BV
M-Protein Interpr.	Unclassified		Sebia Hydrasis LS	90% consensus	4 CAP
MSAFP	Unclassified		Centaur	3 SD	4 CAP
MShCG	Unclassified		Centaur	3 SD	4 CAP
Mucinous carcinoma-associated antigen (M	Unclassified	Serum		18,50%	5 BV
Myoglobin	Unclassified			15 ng/mL or 30%	6 AAB
Myoglobin	Unclassified			30%	8 CFX
Myoglobin	Unclassified	Serum		19,60%	5 BV
Myoglobin - Qualitative	Unclassified			Pos/Neg	2 WSLH
Myoglobin - Quantitative	Unclassified			2 SD	2 WSLH
N-Acetyl Glucosaminidase - Concentration	Unclassified	Urine		53,10%	5 BV
N-Acetyl Glucosaminidase - Output	Unclassified	Urine		46,50%	5 BV
N-Acetyl procainamide	Unclassified			+/- 15%	3 NYS
N-Acetyl procainamide	Unclassified		Abbott AxSym	25%	4 CAP
N-Acetyl procainamide	Unclassified			20%	8 CFX
Napa	Unclassified		Abbott AxSym	25%	4 CAP
Neutrophyles, count	Unclassified	Blood		22,40%	5 BV
Nitrogen - Output	Unclassified	Urine		18,40%	5 BV
Noradrenaline	Unclassified			50 nmol/day, 10%	7 RCPA
Normetanephrine	Unclassified			1,0 umol/day, 33%	7 RCPA
Nortriptyline	Unclassified			10 nmol/L, 10%	7 RCPA
Nortriptyline	Unclassified			15%	8 CFX
NSE	Unclassified			2,0 ug/L, 10%	7 RCPA
N-Telopeptides	Unclassified	Urine		80 nmolBCE/L, 10%	7 RCPA
Oestradiol	Unclassified			100 pmol/L, 20%	7 RCPA
Oestriol - Total	Unclassified			20 nmol/L, 10%	7 RCPA
Oestriol - Unconjugated	Unclassified			5 nmol/L, 20%	7 RCPA
Oligoclonal Bands	Unclassified		Sebia Hydrasis LS	90% consensus	4 CAP
Opiates	Unclassified		Abbott AxSym	80% consensus	4 CAP
Opiates	Unclassified			Pos/Neg	2 WSLH
Opiates	Unclassified			20% or 2 SD	3 NYS
Osmolality	Unclassified	Urine		9. mOsm/kg or 10%	6 AAB
Osmolality	Unclassified			8 mmol/kg	7 RCPA
Osmolality	Unclassified		Freezing point	2 SD	4 CAP
Osmolality	Unclassified			3%	8 CFX
Osmolality	Unclassified	Serum		1,50%	5 BV
Osmolality	Unclassified	Urine	Freezing point	3 SD	4 CAP
Osmolality	Unclassified	Serum		3 SD	2 WSLH
Osmolality	Unclassified	Urine		3 SD	2 WSLH
Osmolality	Unclassified	Urine		6 mmol/kg, 2%	7 RCPA
Osteocalcin	Unclassified	Serum		11,20%	5 BV
Oxalate - Concentration	Unclassified	Urine		48,20%	5 BV
Oxalate - Output	Unclassified	Urine		46,80%	5 BV
Oxyhemoglobin	Unclassified			3 SD	2 WSLH
Oxyhemoglobin	Unclassified		Radiometer 725		4 CAP
PAP	Unclassified			2,5 SD	2 WSLH
Paracetamol	Unclassified			20 umol/L, 10%	7 RCPA
Partial thromboplastin time	Hématologie			+/- 15%	1 CLIA, 2 WSLH, 3 NYS, 6 AAB
pCO2	Unclassified		Radiometer 725	8% or 5 mm Hg (greater)	4 CAP
pCO2	Unclassified			5,0 mm Hg or 8%	6 AAB
pCO2	Unclassified			5 kPa, 8%	8 CFX
pCO2	Unclassified			2,0 mm Hg, 8%	7 RCPA
pCO2	Unclassified	Blood		5,70%	5 BV
pH	Unclassified		Radiometer 725	4%	4 CAP
pH	Unclassified			4%	6 AAB
pH	Unclassified			4%	7 RCPA
pH	Unclassified			4%	8 CFX
pH [H+]	Unclassified	Blood		3,90%	5 BV
pH - Qualitative	Unclassified	Urine		80% Agreement	3 NYS
pH,Fluid	Unclassified		Corning 445 pH meter	4%	4 CAP
Phencyclidine	Unclassified			Pos/Neg	2 WSLH
Phencyclidine	Unclassified		Abbott AxSym	80% consensus	4 CAP
Phencyclidine	Unclassified			20% or 2 SD	3 NYS
Phenobarbital	Toxicologie			+/- 20%	1 CLIA, 2 WSLH, 6 AAB
Phenobarbital	Toxicologie			+/- 15%	3 NYS
Phenobarbital	Toxicologie		Abbott AxSym	20%	4 CAP
Phenobarbital	Toxicologie			20%	8 CFX
Phenobarbitone	Unclassified			3,0 umol/L, 10%	7 RCPA
Phenytoin	Toxicologie			3,0 umol/L, 10%	7 RCPA
Phenytoin	Toxicologie			+/- 25%	1 CLIA, 2 WSLH, 6 AAB
Phenytoin	Toxicologie			+/- 15%	3 NYS
Phenytoin	Toxicologie		Abbott AxSym	25%	4 CAP
Phenytoin	Toxicologie			25%	8 CFX
Phenytoin - Free	Unclassified		TDX	3 SD	4 CAP
Phosphate	Unclassified			0,1 mmol/L, 10%	7 RCPA
Phosphate	Unclassified	Serum		10,20%	5 BV
Phosphate	Unclassified	Urine		2,5 mmol/L	7 RCPA
Phosphate tubular reabsorption	Unclassified	Patient-		3,30%	5 BV
Phosphate - Concentration	Unclassified	Urine		31,10%	5 BV
Phosphate - Output	Unclassified	Urine		22,10%	5 BV
Phospholipids	Unclassified	Serum		8,60%	5 BV
Phosphorus	Unclassified	Urine		3. mg/dL or 15%	6 AAB
Phosphorus	Unclassified		AU640	10,7% or 0,3 mg/dL (greater)	4 CAP
Phosphorus	Unclassified			0,5 mg/dL or 12%	2 WSLH
Phosphorus	Unclassified			0,4 mg/dL or 15%	6 AAB
Phosphorus	Unclassified			+/- 0,45 mg/dL or 13%	3 NYS
Phosphorus	Unclassified			12%	8 CFX
Phosphorus	Unclassified	Urine		0,5 mg/dL or 12%	2 WSLH
Phosphorus	Unclassified	Urine	AU640	23%	4 CAP
Plasma Renin Activity	Unclassified			1,0 ng/mL/hr, 25%	7 RCPA
Plasma Total Porphyrin	Unclassified			3 nmol/L, 15%	7 RCPA
Platelet count	Hématologie			+/- 25%	1 CLIA, 2 WSLH, 3 NYS, 6 AAB
Platelet, count	Unclassified	Blood		13,40%	5 BV
Platelets	Unclassified			25%	6 AAB
pO2	Unclassified			5 mm Hg, 5%	7 RCPA
pO2	Unclassified			3SD	6 AAB
pO2	Unclassified		Radiometer 725	3 SD	4 CAP
pO2	Unclassified			2 SD	8 CFX
Polylysine	Unclassified			45 mmol/L or 30%	6 AAB
Potassium	Chimie		Radiometer 725	0,5 mmol/L	4 CAP
Potassium	Chimie			0,2 mmol/L	7 RCPA
Potassium	Chimie			+/- 0,5 mmol/L	1 CLIA, 2 WSLH, 3 NYS, 6 AAB
Potassium	Chimie	Blood-Leukocyte		16%	5 BV
Potassium	Chimie			6%	8 CFX
Potassium	Chimie	Serum		5,80%	5 BV
Potassium	Unclassified		AU640	0,5 mmol/L	4 CAP
Potassium	Unclassified	Urine		2 SD	2 WSLH
Potassium	Unclassified	Urine	AU640	29%	4 CAP
Potassium	Unclassified	Urine		2,0 mmol/L, 10%	7 RCPA
Potassium - Concentration	Unclassified	Urine		31,30%	5 BV
Potassium - Output	Unclassified	Urine		28,40%	5 BV
Potassium - POCT	Unclassified	POCT		2,0 mmol/L	7 RCPA
Prealbumin	Unclassified		BNII	25% or 5 mg/dL (greater)	4 CAP
Prealbumin	Unclassified	Serum		14,50%	5 BV
Prealbumin	Unclassified			2,5 SD	2 WSLH
Pregnancy	Unclassified	Serum		pos/neg	6 AAB
Primidone	Toxicologie			+/- 25%	1 CLIA, 2 WSLH, 6 AAB
Primidone	Toxicologie			+/- 15%	3 NYS
Primidone	Toxicologie			15%	8 CFX
Procainamide	Unclassified			+/- 15%	3 NYS
Procainamide	Unclassified		Abbott AxSym	25%	4 CAP
Procainamide	Unclassified			25%	6 AAB
Procainamide	Unclassified			20%	8 CFX
Procainamide (and metabolite)	Toxicologie			+/- 25%	1 CLIA, 2 WSLH, 6 AAB
Procainamide, N-Acetyl (NAPA)	Unclassified			25%	6 AAB
Procollagen type 1 N-terminal	Unclassified	Serum		10,50%	5 BV
Progesterone	Unclassified			300 pg/mL or 30%	2 WSLH
Progesterone	Unclassified		Centaur	3 SD	4 CAP
Progesterone	Unclassified			2 SD	8 CFX
Progesterone	Unclassified			2 nmol/L, 25%	7 RCPA
Progesterone	Unclassified			0,3 ng/mL or 30%	6 AAB
Progesterone	Unclassified			+/-25% or 1,0 ng/mL	3 NYS
Prolactin	Unclassified			3,6 ng/mL or 30%	2 WSLH
Prolactin	Unclassified			3,6 ng/mL or 30%	6 AAB
Prolactin	Unclassified		Centaur	3 SD	4 CAP
Prolactin	Unclassified			20 mU/L, 20%	7 RCPA
Prolactin	Unclassified			2 SD	8 CFX
Prolactin	Unclassified			+/-25% or 1,0 ug/L	3 NYS
Prolactin (men)	Unclassified	Serum		21,10%	5 BV
Prolyl endopeptidase	Unclassified	Plasma		19,30%	5 BV
Propoxyphene	Unclassified			Pos/Neg	2 WSLH
Propoxyphene	Unclassified			20% or 2 SD	3 NYS
Prostatic Specific Antigen (PSA)	Unclassified			0,9 ng/mL or 30%	6 AAB
Prostatic Specific Antigen (PSA)	Unclassified	Serum		30%	5 BV
Protein	Unclassified			10%	2 WSLH
Protein - Total	Unclassified			6%	8 CFX
Protein - Total	Unclassified			5,0 g/L	7 RCPA
Protein - Total	Unclassified		AU640	10%	4 CAP
Protein - Total	Unclassified	Serum		3,40%	5 BV
Protein - Total	Unclassified	Urine		80% Agreement	3 NYS
Protein - Total	Unclassified	Urine		10%	2 WSLH
Protein C	Unclassified	Serum		18,70%	5 BV
Protein Electrophoresis Interpretation	Unclassified	Urine	Sebia Hydrasis LS	90% consensus	4 CAP
Protein Electrophoresis Interpretation	Unclassified	Serum	Sebia Hydrasis LS	90% consensus	4 CAP
Protein Electrophoresis Interpretation (24 Hour)	Unclassified	Urine	Sebia Hydrasis LS	90% consensus	4 CAP
Protein S	Unclassified	Plasma		20,70%	5 BV
Protein - Concentration	Unclassified	Urine		43,50%	5 BV
Protein- Output	Unclassified	Urine		40%	5 BV
Prothrombin Time	Hématologie			+/- 15%	1 CLIA, 2 WSLH, 3 NYS, 6 AAB
Prothrombin Time	Hématologie	Plasma		5,30%	5 BV
Prothrombin Time	Unclassified		CoaguChek	15%	6 AAB
Prothrombin Time	Unclassified			15%	6 AAB
Prothrombin Time	Unclassified	Whole Blood		15%	6 AAB
PSA	Unclassified		Abbott AxSym	3 SD	4 CAP
PSA	Unclassified			0,9 ng/mL or 30%	2 WSLH
PSA	Unclassified			+/- 3 SD	3 NYS
PSA - Free	Unclassified			0,9 ng/mL or 30%	2 WSLH
PTH	Unclassified		Centaur	3 SD	4 CAP
PTH	Unclassified			2,5 pmol/L, 25%	7 RCPA
Pyridinoline/creatinine, morning spot	Unclassified	Urine		12,10%	5 BV
Pyruvate	Unclassified	Blood		17,50%	5 BV
Qualitative hCG	Unclassified			Positive or Negative	3 NYS
Quinidine	Toxicologie			2,0 umol/L, 10%	7 RCPA
Quinidine	Toxicologie			+/- 25%	1 CLIA, 2 WSLH, 6 AAB
Quinidine	Toxicologie			+/- 15%	3 NYS
Quinidine	Toxicologie		Abbott AxSym	25%	4 CAP
Quinidine	Toxicologie			25%	8 CFX
RBC Folate	Unclassified			2,5 SD	2 WSLH
RBC Total Porphyrin	Unclassified			0,3 umol/L rc, 15%	7 RCPA
Red cell distribution wide	Unclassified	Blood		4,60%	5 BV
Reticulocyte Count	Unclassified			0,50% or 30%	6 AAB
Reticulocyte highly fluorescent, count	Unclassified	Serum		24%	5 BV
Reticulocyte low fluorescent, count	Unclassified	Serum		2,60%	5 BV
Reticulocyte medium fluorescent, count	Unclassified	Serum		19,60%	5 BV
Reticulocyte, count	Unclassified	Serum		16,80%	5 BV
Reticulocytes	Unclassified			3 SD	2 WSLH
Retinol	Unclassified	Serum		18,10%	5 BV
Rheumatoid Factor	Immunology			Target value +/- 2 dilution or (pos. or neg.)	1 CLIA
Rheumatoid Factor	Immunology	Serum		13,50%	5 BV
Rheumatoid Factor	Unclassified			Positive or Negative or +/- 2 dilutions	3 NYS
Rheumatoid Factor	Unclassified		BNII	2 SD	4 CAP
Rubella	Immunology			Target value +/- 2 dilution or (pos. or neg.)	1 CLIA
Salicylates	Unclassified			0,1 mmol/L, 10%	7 RCPA
Salicylates	Unclassified			+/- 15%	3 NYS
Salicylates	Unclassified			25%	2 WSLH
Salicylates	Unclassified		AU640	3 SD	4 CAP
Salicylates	Unclassified			25%	6 AAB
Salicylates	Unclassified			20%	8 CFX
SCC antigen	Unclassified	Serum		45,80%	5 BV
Sedimentation Rate [ESR]	Unclassified			2,5 SD	2 WSLH
Selenium	Unclassified	Blood		14,50%	5 BV
Selenium	Unclassified	Plasma		14,50%	5 BV
Serotonin	Unclassified			0,3 umol/day, 30%	7 RCPA
Sex hormone binding globulin (SHBG)	Unclassified	Serum		21,10%	5 BV
SHBG	Unclassified			5 nmol/L, 10%	7 RCPA
Sickle Cell Screen	Unclassified			Pos/Neg	2 WSLH
Sodium	Chimie			4 mmol/L, 5%	8 CFX
Sodium	Chimie		Radiometer 725	4 mmol/L	4 CAP
Sodium	Chimie		AU640	4 mmol/L	4 CAP
Sodium	Chimie			3,0 mmol/L	7 RCPA
Sodium	Chimie			+/- 4 mmol/L	1 CLIA, 2 WSLH, 3 NYS, 6 AAB
Sodium	Chimie	Blood-Leukocyte		0,577	5 BV
Sodium	Chimie	Blood-Erythrocytes		0,046	5 BV
Sodium	Chimie	Serum		0,009	5 BV
Sodium	Unclassified	Urine		2 SD	2 WSLH
Sodium	Unclassified	Urine	AU640	26%	4 CAP
Sodium	Unclassified	Sweat		2 mmol/L, 10%	7 RCPA
Sodium	Unclassified	Urine		2,0 mmol/L, 10%	7 RCPA
Sodium - Concentration	Unclassified	Urine		28,80%	5 BV
Sodium - Output	Unclassified	Urine		32%	5 BV
Specific Gravity	Unclassified	Urine		1%	6 AAB
Specific Gravity - Qualitative	Unclassified	Urine		80% Agreement	3 NYS
Sperm Count	Unclassified			3 million/mL or 25%	6 AAB
Sperm Morphology	Unclassified			5% normal or 20%%	6 AAB
Sperm Viability	Unclassified			5% viable or 20%%	6 AAB
Superoxide dismutase	Unclassified	Serum		19,10%	5 BV
Superoxide dismutase	Unclassified	Blood-Erythrocytes		13,50%	5 BV
Sweat Conductivity	Unclassified			2 mmol/L, 10%	7 RCPA
T Uptake	Unclassified			7%	8 CFX
T3 uptake	Endocrinology			+/- 3 SD by method	1 CLIA, 2 WSLH, 3 NYS, 6 AAB
T3 Uptake	Unclassified		Centaur	3 SD	4 CAP
T3, T3	Unclassified		Centaur	3 SD	4 CAP
T3-uptake	Unclassified	Serum		5,30%	5 BV
T4, Free	Unclassified		Centaur	3 SD	4 CAP
T4, Total	Unclassified		Centaur	20% or 1 ug/dL (greater)	4 CAP
Tacrolimus (FK 506)	Unclassified		IMX	3 SD	4 CAP
Testosterone	Unclassified		Centaur	3 SD	4 CAP
Testosterone	Unclassified			2 SD	8 CFX
Testosterone	Unclassified			0,5 nmol/L, 20%	7 RCPA
Testosterone	Unclassified			0,3 ng/mL or 30%	2 WSLH
Testosterone	Unclassified			0,3 ng/mL or 30%	6 AAB
Testosterone	Unclassified			+/-25% or 1,0 ng/dL	3 NYS
Testosterone	Unclassified	Saliva		22,70%	5 BV
Testosterone	Unclassified	Serum		14%	5 BV
Testosterone - Free	Unclassified			0,3 ng/mL or 30%	2 WSLH
THC-cannabinoids	Unclassified			20% or 2 SD	3 NYS
Theophylline	Toxicologie			3,0 umol/L, 10%	7 RCPA
Theophylline	Toxicologie			+/- 25%	1 CLIA, 2 WSLH, 6 AAB
Theophylline	Toxicologie			+/- 15%	3 NYS
Theophylline	Toxicologie		Abbott AxSym	25%	4 CAP
Theophylline	Toxicologie			25%	8 CFX
Thyroglobulin	Unclassified	Serum		17,80%	5 BV
Thyroid Stimulating Hormone (TSH)	Endocrinology			+/- 3 SD	1 CLIA, 2 WSLH, 3 NYS, 6 AAB
Thyroid Stimulating Hormone (TSH)	Unclassified			3SD	6 AAB
Thyroid Stimulating Hormone (TSH)	Unclassified			30%	8 CFX
Thyroid Stimulating Hormone (TSH)	Unclassified	Serum		24,60%	5 BV
Thyroxin binding globulin (TBG)	Unclassified	Serum		7,10%	5 BV
Thyroxine	Endocrinology			8 nmol/L, 15%	7 RCPA
Thyroxine	Endocrinology			+/- 20% or 1,0 mcg/dL (greater)	1 CLIA, 2 WSLH, 3 NYS, 6 AAB
Thyroxine - Free	Unclassified			2 SD	8 CFX
Thyroxine - Total	Unclassified			8%	8 CFX
Thyroxine (T4)	Unclassified	Serum		8,30%	5 BV
Thyroxine - Free	Unclassified			3SD	6 AAB
Thyroxine - Total	Unclassified			1,0 µg/dL or 20%	6 AAB
TIBC	Unclassified			10,0 umol/L	7 RCPA
TIBC	Unclassified		Centaur	20%	4 CAP
Tissue polypeptide antigen (TPA)	Unclassified	Serum		36,10%	5 BV
Tissue polypeptide specific antigen (TPS)	Unclassified	Serum		58,30%	5 BV
Tobramycin	Toxicologie			0,5 mg/L, 10%	7 RCPA
Tobramycin	Toxicologie			+/- 25%	1 CLIA, 2 WSLH, 6 AAB
Tobramycin	Toxicologie			+/- 15%	3 NYS
Tobramycin	Toxicologie		Abbott AxSym	25%	4 CAP
Tobramycin	Toxicologie			25%	8 CFX
Total Beta hCG	Unclassified			+/- 3 SD	3 NYS
Total Bilirubin, Neonatal	Unclassified			15 umol/L, 10%	7 RCPA
Total Carotenoids	Unclassified			0,4 umol/L, 10%	7 RCPA
Total catecolamines - Concentration, 24h	Unclassified	Urine		29,80%	5 BV
Total Estriol	Unclassified			+/-25% or 3,0 ng/mL	3 NYS
Total Glycated Hemoglobin	Unclassified			1,2 or 20%	2 WSLH
Total Iron Binding Capacity (TIBC)	Unclassified			25%	6 AAB
Total Protein	Chimie			+/- 10%	1 CLIA, 2 WSLH, 3 NYS, 6 AAB
Total Protein	Unclassified	Urine		1,0 mg/dL or 25%	6 AAB
Total Protein	Unclassified			10%	6 AAB
Total Protein	Unclassified	Urine	AU640	44%	4 CAP
Total Protein	Unclassified	Cerebrospinal Fluid		0,1 g/L, 10%	7 RCPA
Total Protein	Unclassified	Urine		0,1 g/L, 10%	7 RCPA
Total PSA	Unclassified			1,5 ug/L, 15%	7 RCPA
Total T3 (Endocrinology)	Unclassified			0,3 nmol/L, 20%	7 RCPA
Total T3 (General Chemistry)	Unclassified			0,3 nmol/L, 15%	7 RCPA
Total T4	Unclassified			8 nmol/L, 15%	7 RCPA
Transferrin	Unclassified			2,5 SD	2 WSLH
Transferrin	Unclassified			0,5 g/L	7 RCPA
Transferrin	Unclassified		BNII	20%	4 CAP
Transferrin	Unclassified			12%	8 CFX
Transferrin	Unclassified	Serum		3,80%	5 BV
Tricyclic Antidepressants	Unclassified			Pos/Neg	2 WSLH
Tricyclic Antidepressants	Unclassified			20% or 2 SD	3 NYS
Tricyclic Antidepressants	Unclassified			10 nmol/L, 10%	7 RCPA
Tricyclic Antidepressants	Unclassified			15%	8 CFX
Triglycerides	Unclassified			0,20 mmol/L, 10%	7 RCPA
Triglycerides	Unclassified	Serum		27,90%	5 BV
Triglycerides	Chimie			+/- 25%	1 CLIA, 2 WSLH, 3 NYS, 6 AAB
Triglycerides	Chimie		AU640	25%	4 CAP
Triglycerides	Chimie			15%	8 CFX
Triiodothyronine	Endocrinology			+/- 3 SD	1 CLIA, 2 WSLH, 3 NYS, 6 AAB
Triiodothyronine - Free	Unclassified			20%	8 CFX
Triiodothyronine - Total	Unclassified			20%	8 CFX
Triiodothyronine (T3)	Unclassified	Serum		11,40%	5 BV
Triiodothyronine, Free (Free T3)	Unclassified			1,5 pg/mL or 30%	6 AAB
Triiodothyronine, Total (T3)	Unclassified			3SD	6 AAB
Troponin I	Unclassified		Centaur	not evaluated	4 CAP
Troponin I	Unclassified			2 SD	8 CFX
Troponin I	Unclassified			0,9 ng/mL or 30%	6 AAB
Troponin I	Unclassified			0,2 ng/mL, 10%	7 RCPA
Troponin I - Qualitative	Unclassified			Pos/Neg	2 WSLH
Troponin I - Quantitative	Unclassified			2 SD	2 WSLH
Troponin T	Unclassified			2 SD	8 CFX
Troponin T	Unclassified			0,1 ng/mL, 10%	7 RCPA
Troponin T	Unclassified			0,1 ng/mL or 30%	6 AAB
Troponin T - Qualitative	Unclassified			Pos/Neg	2 WSLH
Troponin T - Quantitative	Unclassified			2 SD	2 WSLH
Thyroid Stimulating Hormone (TSH)	Unclassified		Centaur	3 SD	4 CAP
Thyroid Stimulating Hormone (TSH)	Unclassified			0,6 mU/L, 15%	7 RCPA
Tumor Necrosis Factor-a	Unclassified	Serum		48,40%	5 BV
TUptake	Unclassified			3SD	6 AAB
uE3 (Maternal Sera)	Unclassified	Maternal Sera		+/- 3 SD	3 NYS
Unsaturated Iron Binding Capacity (UIBC)	Unclassified			25%	6 AAB
Urate	Unclassified			0,050 mmol/L	7 RCPA
Urate	Unclassified	Serum		11,90%	5 BV
Urate	Unclassified	Urine		0,3 mmol/L	7 RCPA
Urate - Concentration, 24h	Unclassified	Urine		28,70%	5 BV
Urate- Output, 24h	Unclassified	Urine		21,10%	5 BV
Urea	Unclassified		AU640	9% or 2 mg N/dL (greater)	4 CAP
Urea	Unclassified			0,1 mmol/L, 10%	7 RCPA
Urea	Unclassified	Serum		15,70%	5 BV
Urea	Unclassified	Urine		20 mmol/L, 10%	7 RCPA
Urea	Unclassified	Urine	AU640	21%	4 CAP
Urea Nitrogen	Chimie			+/- 2 mg/dL or +/- 9% (greater)	1 CLIA
Urea Nitrogen	Unclassified	Urine		2 mg/dL or 9%	2 WSLH
Urea - Concentration, 24h	Unclassified	Urine		27,30%	5 BV
Urea - Output, 24h	Unclassified	Urine		22,10%	5 BV
Urea/Urea Nitrogen	Unclassified			16%	8 CFX
Urea-POCT	Unclassified	POCT		1,0 mmol/L, 10%	7 RCPA
Uric Acid	Chimie			+/- 17%	1 CLIA, 2 WSLH, 3 NYS, 6 AAB
Uric Acid	Unclassified	Urine		17%	6 AAB
Uric Acid	Unclassified			17%	6 AAB
Uric Acid	Unclassified			12%	8 CFX
Uric Acid	Unclassified	Urine		17%	2 WSLH
Uric Acid	Unclassified	Urine	AU640	24%	4 CAP
Uric Acid	Chimie		AU640	17%	4 CAP
Urine ALA	Unclassified			5 umol/L, 25%	7 RCPA
Urine Porphobilinogen - Quantitative	Unclassified			5 umol/L, 20%	7 RCPA
Urine Total Porphyrin	Unclassified			15 nmol/L, 15%	7 RCPA
Valproate	Unclassified			25 umol/L, 10%	7 RCPA
Valproic Acid	Toxicologie			+/- 25%	1 CLIA, 2 WSLH, 6 AAB
Valproic Acid	Toxicologie			+/- 15%	3 NYS
Valproic Acid	Unclassified		Abbott AxSym	25%	4 CAP
Valproic Acid	Unclassified			25%	6 AAB
Valproic Acid	Unclassified			15%	8 CFX
Valproic Acid, free	Unclassified		TDX	3 SD	4 CAP
Vancomycin	Unclassified		Abbott AxSym	3 SD	4 CAP
Vancomycin	Unclassified			2,0 mg/L, 10%	7 RCPA
Vancomycin	Unclassified			1,5 ug/mL or 25%	6 AAB
Vancomycin	Unclassified			+/- 15%	3 NYS
Vancomycin	Unclassified			25%	2 WSLH
Vancomycin	Unclassified			20%	8 CFX
Vanilmandelic Acid concentration, 24h	Unclassified	Urine		31,30%	5 BV
Vitamin A	Unclassified			0,3 umol/L, 10%	7 RCPA
Vitamin B-12	Unclassified			60 pg/mL or 30%	2 WSLH
Vitamin B-12	Unclassified			60 pg/mL or 30%	6 AAB
Vitamin B-12	Unclassified			20 pmol/L, 20%	7 RCPA
Vitamin B-12	Unclassified			+/- 25%	3 NYS
Vitamin B-12	Unclassified		Centaur	3 SD	4 CAP
Vitamin D3	Unclassified			5 nmol/L, 15	7 RCPA
Vitamin E	Unclassified			5,0 umol/L, 10%	7 RCPA
Von Willebrand factor	Unclassified	Plasma		7,40%	5 BV
Water	Unclassified	Serum		3,30%	5 BV
White cell differentiation	Hématologie			Target +/- 3 SD based on percentage of different types of white cells	1 CLIA, 2 WSLH
Zinc	Unclassified	Serum		13,50%	5 BV
Zinc	Unclassified	Plasma		11%	5 BV
ZPP	Unclassified			+/-15% (µmol/mol heme)	3 NYS

Abbreviations and Sources

Abbreviation	Source
1 CLIA	CLIA ’88, CLIA
2 WLSH	Wisconsin State Laboratory of Hygiene
3 NYS	Wadsworth Center of the New York State Department of Health
4 CAP	College of American Pathologists (CAP)
5 BV	2004 update of the Spanish Society of Clinical Chemistry and Molecular Pathology (SEQC) table of Desirable Quality Specifications based on Biological Variation.
6 AAB	American Association of Bioanalysts (AAB)
7 RCPA	The Royal College of Pathologists of Australasia and the Australasian Clinical Biochemist association Quality Assurance Program
8 CFX	Canadian Fixed limits from the College of Physicians and Surgeons of Saskatchewan

Total Allowable Error Table

Total Allowable Error Table

Total Allowable Error Table

Total Allowable Error Table (Updated 20 juin24)

Sources

Total Allowable Error Table (Prior to 20 juin24)

Abbreviations and Sources

Vous souhaitez en apprendre davantage ?

ETATS-UNIS MAISON MÈRE

BUREAU EUROPÉEN

BUREAU EN AMÉRIQUE LATINE

BUREAU EN ASIE-PACIFIQUE